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A B S T R A C T
Background
Surgical resection is currently the only treatment with the potential for long-term survival and cure of pancreatic cancer. Surgical
resection is provided as distal pancreatectomy for cancers of the body and tail of the pancreas. It can be performed by laparoscopic or
open surgery. In operations on other organs, laparoscopic surgery has been shown to reduce complications and length of hospital stay
as compared with open surgery. However, concerns remain about the safety of laparoscopic distal pancreatectomy compared with open
distal pancreatectomy in terms of postoperative complications and oncological clearance.
Objectives
To assess the benefits and harms of laparoscopic distal pancreatectomy versus open distal pancreatectomy for people undergoing distal
pancreatectomy for pancreatic ductal adenocarcinoma of the body or tail of the pancreas, or both.
Search methods
We used search strategies to search the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, Science
Citation Index Expanded and trials registers until June 2015 to identify randomised controlled trials (RCTs) and non-randomised
studies. We also searched the reference lists of included trials to identify additional studies.
Selection criteria
We considered for inclusion in the review RCTs and non-randomised studies comparing laparoscopic versus open distal pancreatectomy
in patients with resectable pancreatic cancer, irrespective of language, blinding or publication status..
Data collection and analysis
Two review authors independently identified trials and independently extracted data. We calculated odds ratios (ORs), mean differences
(MDs) or hazard ratios (HRs) along with 95% confidence intervals (CIs) using both fixed-effect and random-effects models with
RevMan 5 on the basis of intention-to-treat analysis when possible.
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Main results
We found no RCTs on this topic. We included in this review 12 non-randomised studies that compared laparoscopic versus open
distal pancreatectomy (1576 participants: 394 underwent laparoscopic distal pancreatectomy and 1182 underwent open distal pan-
createctomy); 11 studies (1506 participants: 353 undergoing laparoscopic distal pancreatectomy and 1153 undergoing open distal
pancreatectomy) provided information for one or more outcomes. All of these studies were retrospective cohort-like studies or case-
control studies. Most were at unclear or high risk of bias, and the overall quality of evidence was very low for all reported outcomes.
Differences in short-term mortality (laparoscopic group: 1/329 (adjusted proportion based on meta-analysis estimate: 0.5%) vs open
group: 11/1122 (1%); OR 0.48, 95% CI 0.11 to 2.17; 1451 participants; nine studies; I2 = 0%), long-term mortality (HR 0.96, 95%
CI 0.82 to 1.12; 277 participants; three studies; I2 = 0%), proportion of people with serious adverse events (laparoscopic group: 7/89
(adjusted proportion: 8.8%) vs open group: 6/117 (5.1%); OR 1.79, 95% CI 0.53 to 6.06; 206 participants; three studies; I2 = 0%),
proportion of people with a clinically significant pancreatic fistula (laparoscopic group: 9/109 (adjusted proportion: 7.7%) vs open
group: 9/137 (6.6%); OR 1.19, 95%CI 0.47 to 3.02; 246 participants; four studies; I2 = 61%) were imprecise. Differences in recurrence
at maximal follow-up (laparoscopic group: 37/81 (adjusted proportion based on meta-analysis estimate: 36.3%) vs open group: 59/103
(49.5%); OR 0.58, 95% CI 0.32 to 1.05; 184 participants; two studies; I2 = 13%), adverse events of any severity (laparoscopic group:
33/109 (adjusted proportion: 31.7%) vs open group: 45/137 (32.8%); OR 0.95, 95% CI 0.54 to 1.66; 246 participants; four studies;
I2 = 18%) and proportion of participants with positive resection margins (laparoscopic group: 49/333 (adjusted proportion based on
meta-analysis estimate: 14.3%) vs open group: 208/1133 (18.4%); OR 0.74, 95% CI 0.49 to 1.10; 1466 participants; 10 studies; I
2 = 6%) were also imprecise. Mean length of hospital stay was shorter by 2.43 days in the laparoscopic group than in the open group
(MD -2.43 days, 95% CI -3.13 to -1.73; 1068 participants; five studies; I2 = 0%). None of the included studies reported quality of life
at any point in time, recurrence within six months, time to return to normal activity and time to return to work or blood transfusion
requirements.
Authors’ conclusions
Currently, no randomised controlled trials have compared laparoscopic distal pancreatectomy versus open distal pancreatectomy for
patients with pancreatic cancers. In observational studies, laparoscopic distal pancreatectomy has been associated with shorter hospital
stay as compared with open distal pancreatectomy. Currently, no information is available to determine a causal association in the
differences between laparoscopic versus open distal pancreatectomy. Observed differences may be a result of confounding due to
laparoscopic operation on less extensive cancer and open surgery on more extensive cancer. In addition, differences in length of hospital
stay are relevant only if laparoscopic and open surgery procedures are equivalent oncologically. This information is not available currently.
Thus, randomised controlled trials are needed to compare laparoscopic distal pancreatectomy versus open distal pancreatectomy with
at least two to three years of follow-up. Such studies should include patient-oriented outcomes such as short-term mortality and long-
term mortality (at least two to three years); health-related quality of life; complications and the sequelae of complications; resection
margins; measures of earlier postoperative recovery such as length of hospital stay, time to return to normal activity and time to return
to work (in those who are employed); and recurrence of cancer.
P L A I N L A N G U A G E S U M M A R Y
Key-hole (laparoscopic) versus standard access (open) abdominal operation for people with pancreatic cancer
Review question
How does key-hole (laparoscopic) abdominal surgery compare with standard access (open) abdominal operation for people with
pancreatic cancer?
Background
The pancreas is an organ in the abdomen that secretes pancreatic juice that aids digestion and contains cells that produce important
hormones such as insulin. The pancreas can be divided into the head of the pancreas (right part of the pancreas) and the body and
tail of the pancreas (left part or distal part of the pancreas). Distal pancreatic cancer is cancer of the body and/or tail of the pancreas.
Removal of distal pancreatic cancer by surgery (distal pancreatectomy) is the preferred treatment for people with distal pancreatic
cancers limited to the pancreas who are likely to withstand major surgery, because no other treatments have the potential to cure
pancreatic cancer. Cancer can be removed through an abdominal operation, either laparoscopic distal pancreatectomy or open distal
pancreatectomy. Laparoscopic distal pancreatectomy is a relatively new procedure as compared with the well-established open distal
2Laparoscopic versus open distal pancreatectomy for pancreatic cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
pancreatectomy. In operations on other parts of the body, laparoscopic surgery has been shown to reduce complications and length of
hospital stay as compared with open surgery. However, concerns remain about the safety of laparoscopic distal pancreatectomy in terms
of complications after operation (postoperative complications). In addition, it is not clear whether laparoscopic distal pancreatectomy
achieves the same amount of cancer clearance as is attained by open distal pancreatectomy. It also is not clear whether laparoscopic
distal pancreatectomy is better than open distal pancreatectomy in terms of earlier recovery after operation. We sought to resolve this
issue by searching the medical literature for studies on this topic until June 2015.
Study characteristics
No randomised controlled trials have examined this topic. Randomised controlled trials are the best studies for finding out whether one
treatment is better or worse than another because they ensure that similar types of people are receiving the treatments being assessed. In
the absence of randomised controlled trials, we sought information from non-randomised studies. We identified 12 non-randomised
studies that compared laparoscopic versus open distal pancreatectomy in a total of 1576 patients. One of these studies did not provide
results in a useable way. Thus, we included 11 studies in which a total of 1506 patients underwent distal pancreatectomy. Some
353 patients underwent laparoscopic distal pancreatectomy, and 1153 patients underwent open distal pancreatectomy. In all studies,
historical information was collected from hospital records (retrospective studies). In general, historical information is less reliable than
newly collected (prospective) information and findings of randomised controlled trials.
Key results
Differences in short-term deaths, long-term deaths, percentage of people with major complications, percentage of people with a
pancreatic fistula (abnormal communication between the pancreas and other organs or the skin), recurrence of cancer at final time of
follow-up of participants, percentage of people with any complications and percentage of patients in whom cancer was not completely
removed were imprecise. Average length of hospital stay was shorter in the laparoscopic group than in the open group by about two
days. However, this is not relevant until we can be sure that cancer cures are similar between laparoscopic surgery and open surgery.
No studies have reported quality of life at any point in time, short-term recurrence of cancer, time to return to normal activity, time to
return to work or blood transfusion requirements.
Quality of the evidence
The quality of the evidence was very low, mainly because it was not clear whether similar types of participants received laparoscopic
and open distal pancreatectomy. In many studies, people with less extensive cancer received laparoscopic surgery, and those with more
extensive cancer received open surgery. This makes study findings unreliable. Well-designed randomised controlled trials are necessary
if we are to obtain good quality evidence on this topic.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Laparoscopic distal pancreatectomy compared with open distal pancreatectomy for pancreatic cancer
Patient or population: patients with pancreatic cancer
Settings: secondary or tertiary care centre
Intervention: laparoscopic distal pancreatectomy
Comparison: open distal pancreatectomy
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Quality of the evidence
(GRADE)
Assumed risk Corresponding risk
Open distal pancreatectomy Laparoscopic distal pancre-
atectomy
Short-term mortality 10 per 1000 5 per 1000
(1 to 22)
OR 0.48
(0.11 to 2.17)
1451
(9 studies)
⊕©©©
Very lowa,b
Long-term mortality
Follow-up: 2 to 3 years
549 per 1000 535 per 1000
(480 to 590)
HR 0.96
(0.82 to 1.12)
277
(3 studies)
⊕©©©
Very lowa,c
Serious adverse events (pro-
portion)
51 per 1000 88 per 1000
(28 to 247)
OR 1.79
(0.53 to 6.06)
206
(3 studies)
⊕©©©
Very lowa,b,c
Pancreatic fistula (grade B or
C)
66 per 1000 77 per 1000
(32 to 175)
OR 1.19
(0.47 to 3.02)
246
(4 studies)
⊕©©©
Very lowa,b,c,d
None of the studies reported quality of life at any time point
*The basis for the assumed risk is the mean control group proportion. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and
the relative effect of the intervention (and its 95% CI)
CI: confidence interval; HR: hazard ratio; OR: odds ratio
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate
Very low quality: We are very uncertain about the estimate
a We found no randomised controlled trials. The non-randomised studies included in this review were at unclear or high risk of bias for
most domains
bConfidence intervals were wide
cSample size was small
d I2 was high and little overlap of confidence intervals was evident.
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B A C K G R O U N D
Description of the condition
Adenocarcinoma of the pancreas is the most common malignancy
of the exocrine pancreas. It is the tenth most common cancer
in the United States, the fifth most common cause of cancer-re-
lated mortality in the East and the fourth most common cause of
cancer-related mortality in the West (Parkin 2001; Parkin 2005;
Yamamoto 1998). In 2012, 338,000 people were newly diagnosed
with pancreatic cancer, and 330,000 deaths were the result of pan-
creatic cancer globally (IARC 2014). Global variation has been
noted in the incidence of pancreatic cancer, with an age-standard-
ised annual incidence rate of 7.2 per 100,000 in more developed
regions and an age-standardised annual incidence rate of 2.8 per
100,000 in less developed regions (IARC 2014). A similar trend
has been noted in an age-standardised annual mortality rate of 6.8
per 100,000 population in more developed regions and 2.7 per
100,000 population in less developed regions due to pancreatic
cancer (IARC 2014). Mortality rates due to pancreatic cancer are
increasing in the United States (Ma 2013). Pancreatic adenocar-
cinoma has a poor prognosis for many reasons. It is a biologically
aggressive cancer that is relatively resistant to chemotherapy and
radiotherapy and has a high rate of local and systemic recurrence
(Abrams 2009; Ghaneh 2007; Orr 2010). Surgical resection re-
mains the only treatment with the potential for long-term sur-
vival and cure. However, about half the people have metastatic
disease at presentation, and one-third have locally advanced un-
resectable disease, leaving only about 10% to 20% of people suit-
able for resection (Tucker 2008). Overall five-year survival af-
ter radical resection ranges from 7% to 25% (Cameron 1993;
Livingston 1991; Niederhuber 1995; Nitecki 1995; Orr 2010;
Trede 1990), with median survival of 11 to 15 months (British
Society of Gastroenterology 2005). With adjuvant chemotherapy,
median survival after radical resection ranges between 14 and 24
months (Liao 2013).
Pancreatic cancer can occur in the head of the pancreas or in the
body and tail of the pancreas. In early pancreatic cancer (with
no invasion of adjacent structures such as the superior mesenteric
vein, portal vein or superior mesenteric artery), surgical resection
remains the primary treatment of choice for people likely to with-
stand major surgery.
Description of the intervention
Surgical resection is provided as pancreaticoduodenectomy for
cancers of the head of the pancreas and as distal pancreatectomy
for cancers of the body and tail of the pancreas (Park 2013). In
open distal pancreatectomy, surgical access to the abdominal cav-
ity (and hence the pancreas) is attained by upper midline inci-
sion, bilateral subcostal incision (roof-top or Chevron incision)
or transverse abdominal incision (Fernandez-Cruz 2006). In la-
paroscopic distal pancreatectomy, surgical access to the abdominal
cavity (and hence the pancreas) is typically attained by four small
ports (holes) of about 1 cm each through which laparoscopic in-
struments can be inserted after the abdomen is distended using
carbon dioxide pneumoperitoneum. For people with pancreatic
cancer, the pancreas and the spleen are removed together (en bloc)
after isolation and mobilisation of the distal pancreas, spleen and
surrounding lymph nodes from surrounding structures such as
the stomach, colon, diaphragm and kidneys by dividing attach-
ments and blood vessels (Fernandez-Cruz 2006). Although splenic
preservation is possible in open or laparoscopic distal pancreatec-
tomy (Fernandez-Cruz 2006), the spleen is usually removed dur-
ing distal pancreatectomy for cancers because of concern about
cancer clearance in spleen preservation surgeries (Fernandez-Cruz
2005). However, no evidence suggests that splenectomy improves
cancer clearance.
After resection of the body and tail of the pancreas, the cut sur-
face of the pancreatic remnant (pancreatic stump) is usually closed
with staples or sutures (Diener 2011). Despite this, a high inci-
dence of clinically significant pancreatic fistula (11%) has been re-
ported (Diener 2011; Montorsi 2012), and various interventions
including somatostatin analogues may be used to decrease pancre-
atic fluid secretion (Gurusamy 2013), and fibrin sealants (in the
form of glue (Suzuki 1995) or patches (Montorsi 2012)) to seal
the pancreatic stump.
Distal pancreatectomy can also be performed with the assistance
of a robot (robot-assisted distal pancreatectomy). In robot-assisted
distal pancreatectomy, laparoscopic instruments are controlled by
a robot. This is generally considered distinct from laparoscopic
distal pancreatectomy (Daouadi 2013). The term ’minimally in-
vasive distal pancreatectomy’ is usually used to describe both la-
paroscopic distal pancreatectomy and robot-assisted distal pancre-
atectomy.
How the intervention might work
For many surgical procedures, laparoscopic surgery is currently
preferred over open surgery. Laparoscopic surgery includes surgi-
cal procedures such as cholecystectomy (removal of gallbladder),
colon cancer treatment and hysterectomy (Bijen 2009; Keus 2006;
Reza 2006; Talseth 2014; Walsh 2009). Laparoscopic surgery is
preferred over open surgery because it is associated with decreased
pain, decreased blood loss, shorter hospital stay, earlier postopera-
tive recovery, better cosmesis (physical appearance) and decreased
costs (Bijen 2009;Keus2006;Kooby 2008;Reza 2006;Rutz 2014;
Talseth 2014; Walsh 2009).
Why it is important to do this review
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A smaller incision and earlier postoperative recovery appear to be
potential advantages of laparoscopic distal pancreatectomy; how-
ever, the safety of this approach for a procedure that has a high com-
plication rate and cancer clearance after laparoscopic distal pan-
createctomymust be ensured before themethod can be widely rec-
ommended. Healthcare providers have expressed concerns about
cancer clearance because port-site metastases (recurrence of cancer
at the laparoscopic port site) have been reported after laparoscopic
surgery for many different cancers (Kais 2014; Palomba 2014;
Song 2014). Animal research has shown that increased intra-ab-
dominal pressure during laparoscopy (pneumoperitoneum) may
drive malignant cells into ports, resulting in seeding of the port
site and port-site metastases (Hopkins 1999). Also, malignant cells
may be adherent to laparoscopic instruments that are introduced
and removed through the ports, resulting in seeding of the port
site and port-site metastases (Hopkins 1999). Other issues include
the adequacy of cancer clearance in terms of resection margins and
the extent of lymph nodes removed through laparoscopy. There-
fore, oncological efficacy (cancer clearance) is an important issue
with laparoscopic distal pancreatectomy. No Cochrane review has
examined this topic.
O B J E C T I V E S
To assess the benefits and harms of laparoscopic distal pancreate-
ctomy versus open distal pancreatectomy for people undergoing
distal pancreatectomy for pancreatic ductal adenocarcinoma of the
body or tail of the pancreas, or both.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We planned to include only randomised controlled trials (RCTs)
in this review. However, we found no RCTs on the topic, so we
performed a meta-analysis of observational studies clearly high-
lighting the bias involved in interpretation of results. We included
studies reported as full text, studies published as abstract only and
unpublished data.
Types of participants
We included adults undergoing distal pancreatectomy for pancre-
atic ductal adenocarcinoma. Although we excluded people under-
going distal pancreatectomy for neuroendocrine cancers (cancers
that arise from neural and endocrine cells; Rindi 2011), when pos-
sible we included trials in which no separate outcome data were
available for people undergoing distal pancreatectomy for pan-
creatic adenocarcinoma, provided that distal pancreatectomy for
other causes including neuroendocrine cancer was performed in
less than 10% of participants included in the trial.
Types of interventions
We included trials comparing laparoscopic distal pancreatectomy
versus open distal pancreatectomy provided that the only differ-
ence between groups was the use of the laparoscopic or open
method of access to the pancreas. We excluded studies that com-
pared different methods of laparoscopic distal pancreatectomy,
robotic distal pancreatectomy or open distal pancreatectomy.
Types of outcome measures
Primary outcomes
1. Mortality.
i) Short-term mortality (in-hospital mortality or
mortality within three months).
ii) Long-term mortality.
2. Serious adverse events (within three months). We will
accept the following definitions of serious adverse events.
i) Clavien-Dindo classification (Clavien 2009; Dindo
2004): grade III or greater.
ii) International Conference on Harmonisation - Good
Clinical Practice (ICH-GCP) guideline (ICH-GCP 1996):
serious adverse events defined as any untoward medical
occurrences that result in death, are life-threatening, require
hospitalisation or prolongation of existing hospitalisation or
result in persistent or significant disability/incapacity.
iii) Individual complications that can clearly be classified
as grade III or greater with the Clavien-Dindo classification
(Clavien 2009; Dindo 2004), or as a serious adverse event with
the ICH-GCP classification.
iv) Clinically significant pancreatic fistulas (type B or type
C International Study Group on Pancreatic Fistula (ISGPF)
definition) (Bassi 2005).
3. Health-related quality of life (using any validated scale).
i) Short-term (four weeks to three months).
ii) Medium-term (longer than three months to one year).
Secondary outcomes
1. Recurrence (local recurrence, surgical wound recurrence
(also called port-site metastasis in the laparoscopic group) or
distal metastasis).
i) Short-term recurrence (within six months).
ii) Long-term recurrence (recurrence at maximal follow-
up).
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2. Adverse events (within three months). We will accept all
adverse events reported by the study author irrespective of their
severity.
3. Perioperative blood transfusion requirements (during
surgery or within one week after surgery) (whole blood or red
cell transfusion).
i) Proportion of people requiring blood transfusion.
ii) Quantity of blood transfusion.
4. Measures of earlier postoperative recovery.
i) Length of hospital stay (including the index admission
for distal pancreatectomy and any surgical complication-related
re-admissions).
ii) Time to return to normal activity (return to
preoperative mobility with no additional carer support).
iii) Time to return to work (for people who were
employed previously).
5. Positive resection margins (presence of macroscopic or
microscopic cancer tissue at the plane of resection) at
histopathological examination after surgery.
We based our choice of clinical outcomes (above) on the neces-
sity to assess whether laparoscopic surgery results in adequate can-
cer clearance, is safe and is beneficial in terms of decreased blood
transfusion requirements; earlier postoperative recovery, allowing
earlier discharge from hospital, return to normal activity and re-
turn to work; and improvement in health-related quality of life.
We highlighted that positive resection margins at histopathologi-
cal examination after surgery represent a surrogate outcome, and
we have included this to explore whether positive resection mar-
gins after surgery are responsible for any differences in survival or
mortality.
We included studies that met the inclusion criteria irrespective of
whether they reported our secondary outcomes.
Search methods for identification of studies
Electronic searches
We conducted a literature search to identify all published and
unpublished RCTs and non-randomised studies and to identify
potential studies in all languages. We translated non-English lan-
guage papers and assessed them for potential inclusion in the re-
view as necessary.
We searched the following electronic databases to identify poten-
tial studies.
1. The Cochrane Central Register of Controlled Trials
(CENTRAL) (2015, Issue 6) (Appendix 1).
2. MEDLINE (1966 to June 2015) (Appendix 2).
3. EMBASE (1988 to June 2015) (Appendix 3).
4. Science Citation Index (1982 to June 2015) (Appendix 4).
We
also conducted a search of ClinicalTrials.gov (ClinicalTrials.gov;
Appendix 5) and the World Health Organization International
Clinical Trials Registry Platform (WHO ICTRP; www.who.int/
ictrp/en/; Appendix 6) on 20 June 2015.
Searching other resources
We checked the reference lists of all primary studies and review ar-
ticles for additional references. We contacted authors of identified
trials and asked them to identify other published and unpublished
studies.
We searched PubMed for errata or retractions from eligible trials
(www.ncbi.nlm.nih.gov/pubmed) on 14 December 2015.
Data collection and analysis
Selection of studies
Two review authors (D Riviere and K Gurusamy) independently
screened titles and abstracts for inclusion of all potential studies
identified as a result of the search and coded them as ’retrieve’
(eligible or potentially eligible/unclear) or ’do not retrieve’. We re-
trieved full-text study reports, and two review authors (D Riviere
andKGurusamy) independently screened these reports, identified
studies for inclusion and identified and recorded reasons for exclu-
sion of ineligible studies. We resolved disagreements through dis-
cussion and identified and excluded duplicates and collated mul-
tiple reports of the same study, so that each study, rather than each
report, was the unit of interest in the review.We recorded the selec-
tion process in sufficient detail to complete a PRISMA (Preferred
Reporting Items for Systematic Reviews and Meta-Analyses) flow
diagram and Characteristics of excluded studies table.
Data extraction and management
We used a standard data collection form that had been piloted on
at least one study in the review to record study characteristics and
outcome data. Two review authors (D Riviere and K Gurusamy)
extracted study characteristics from included studies and detailed
them in a Characteristics of included studies table. We extracted
the following study characteristics.
1. Methods: study design, total study duration and run-in,
number of study centres and locations, study settings,
withdrawals, date of study.
2. Participants: number, mean age, age range, gender,
American Society of Anesthesiologists (ASA) status (ASA 2014),
inclusion criteria, exclusion criteria.
3. Interventions: intervention, comparison, concomitant
interventions.
4. Outcomes: primary and secondary outcomes specified and
collected, time points reported.
5. Notes: funding for trial, notable conflicts of interest of trial
authors.
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Two review authors (D Riviere and K Gurusamy) independently
extracted outcome data from included studies. If outcomes were
reported multiple times for the same time frame, for example, if
short-term health-related quality of life was reported at six weeks
and at three months, we chose the later time point (i.e. three
months) for data extraction. For time-to-event outcomes forwhich
data were censored, we extracted data to calculate the natural log-
arithm of the hazard ratio (HR) and its standard error using the
methods suggested by Parmar et al. (Parmar 1998).
We included all randomised participants for medium-term and
long-term outcomes (e.g. mortality, quality of life), and this will
not be conditional upon short-term outcomes (e.g. being alive at
three months, having a low or high quality-of-life index at three
months).
We noted in the Characteristics of included studies table whether
outcome data ware reported in an unuseable way. We resolved dis-
agreements by consensus. One review author (D Riviere) copied
data from the data collection form into Review Manager 5
(RevMan 2014). We double-checked that the data were entered
correctly by comparing study reports versus how the data were
presented in the systematic review.
Assessment of risk of bias in included studies
Two review authors (D Riviere and K Gurusamy) independently
assessed risk of bias for each study. We planned to use the crite-
ria outlined in the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011). However, because randomised con-
trolled trials on the topic were insufficient, we used relevant risk of
bias domains from ’A Cochrane Risk Of Bias Assessment Tool: for
Non-Randomized Studies of Interventions’ (ACROBAT-NRSI)
(Sterne 2014).
We assessed risk of bias according to the following domains.
1. Bias due to confounding.
2. Bias due to selection of participants.
3. Bias due to departure from intended intervention.
4. Bias in measurement of outcomes.
5. Bias due to missing data.
6. Bias in selection of reported findings.
We resolved disagreements by discussion.
We graded each potential source of bias as critical, serious, mod-
erate, low or no information and provided a quote from the study
report together with a justification for our judgement in the ’Risk
of bias’ table. We summarised risk of bias judgements across dif-
ferent studies for each of the domains listed.We considered blind-
ing separately for different key outcomes when necessary (e.g. for
unblinded outcome assessment, risk of bias for all-cause mortal-
ity may be very different from a participant-reported pain scale).
When information on risk of bias relates to unpublished data or
correspondence with a trialist, we noted this in the ’Risk of bias’
table.
When considering treatment effects, we took into account the risk
of bias for studies that contributed to each outcome.
Assessment of bias in conducting the systematic
review
We conducted the review according to the published protocol and
reported deviations from it in the Differences between protocol
and review section of the systematic review.
Measures of treatment effect
We analysed dichotomous data as odds ratio (OR) and continuous
data as mean difference (MD) when the outcome was reported or
was converted to the same units in all trials (e.g. hospital stay). We
planned to calculate standardised mean difference (SMD) when
different scales were used for measuring the outcome (e.g. quality
of life) and planned to ensure that higher scores for continuous
outcomes have the same meaning for the particular outcome, ex-
plain the direction to the reader and report when the directions
were reversed, if this was necessary. We planned to calculate the
rate ratio (RaR) for outcomes such as adverse events and serious
adverse events, when it was possible for the same person to develop
more than one adverse event (or serious adverse event). If study
authors had calculated the RaR of adverse events (or serious ad-
verse events) in the intervention versus control based on Poisson
regression, we planned to obtain the RaR by the Poisson regres-
sion method in preference to RaR calculated on the basis of the
number of adverse events (or serious adverse events) that occurred
during a certain period. We calculated the HR for time-to-event
outcomes such as long-term mortality.
We undertook meta-analyses only when this was meaningful (i.e.
when treatments, participants and the underlying clinical question
were similar enough for pooling to make sense).
Trialists commonly indicate when they have skewed data by re-
porting medians and interquartile ranges. When we encountered
this, we planned to note that the data were skewed by following
the rough guide for identifying skewed distribution available in
the Cochrane Handbook for Systematic Reviews of Interventions and
considered the implication of this.
When multiple trial arms were reported in a single trial, we in-
cluded only the relevant arms. If two comparisons (e.g. laparo-
scopic distal pancreatectomy method 1 vs open pancreatectomy,
laparoscopic distal pancreatectomy method 2 vs open pancreatec-
tomy) must be entered into the same meta-analysis, we planned to
half the control group to avoid double-counting. The alternative
way of including such trials with multiple arms is to pool the re-
sults of laparoscopic distal pancreatectomy method 1 and laparo-
scopic distal pancreatectomy method 2 and compare these with
open pancreatectomy.We planned to perform a sensitivity analysis
to determine whether results of the two methods of dealing with
multi-arm trials led to different conclusions. However, we found
no study with more than two arms that could be included in this
review.
Unit of analysis issues
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The unit of analysis was the individual participant undergoing dis-
tal pancreatectomy. As expected, we found no cluster-randomised
trials for this comparison.
Dealing with missing data
We contacted investigators or study sponsors to verify key study
characteristics and to obtain missing numerical outcome data
when possible (e.g. when a study was identified as abstract only).
If we were not able to obtain the information from investigators
or study sponsors, we imputed mean frommedian (i.e. considered
median as the mean) and calculated standard deviation from stan-
dard error, interquartile range or P value according to theCochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011),
but we assessed the impact of including such studies as indicated
in a sensitivity analysis. Standard deviation could be calculated
from P values; therefore, we did not impute standard deviation as
the highest standard deviation in remaining trials included in the
outcome.
Assessment of heterogeneity
We used the I2 statistic to measure heterogeneity among the trials
in each analysis. If we identified substantial heterogeneity as per
the Cochrane Handbook for Systematic Reviews of Interventions (>
50% to 60%; Higgins 2011), we planned to explore this through
prespecified subgroup analysis).
Assessment of reporting biases
We attempted to contact study authors to ask them to provide
missing outcome data. When this was not possible, and when
missing data were thought to introduce serious bias, we planned
to explore the impact of including such studies in the overall as-
sessment of results by using a sensitivity analysis.
If we were able to pool more than 10 trials, we created and exam-
ined a funnel plot to explore possible publication biases. We used
Egger’s test to determine the statistical significance of the report-
ing bias (Egger 1997). We considered a P value less than 0.05 as
statistically significant reporting bias.
Data synthesis
We performed analyses using Review Manager 5 (RevMan 2014).
We calculated 95% confidence intervals for the treatment effect
and used the Mantel-Haenszel method for dichotomous data, the
inverse variance method for continuous data and generic inverse
variance for time-to-event data.We planned to use the inverse vari-
ance method for count data. We used both fixed-effect (Demets
1987) and random-effects models (DerSimonian 1986) for the
analysis. In case of discrepancy between the two models, we re-
ported both results; otherwise, we reported only results from the
fixed-effect model.
’Summary of findings’ table
We created a ’Summary of findings’ table by using all selected
outcomes. We used the five GRADE (Grades of Recommenda-
tion, Assessment, Development and Evaluation Working Group)
considerations (study limitations, consistency of effect, impreci-
sion, indirectness and publication bias) to assess the quality of a
body of evidence as it relates to studies that contributed data to
the meta-analyses for prespecified outcomes. We used methods
and recommendations described in Section 8.5 and Chapter 12
of the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011) and GRADEpro software. We justified all deci-
sions to downgrade or upgrade the quality of studies by using foot-
notes, and we made comments to aid the reader’s understanding
of the review when necessary. We considered whether any addi-
tional outcome information was provided that we were unable to
incorporate into meta-analyses, and we planned to note this in the
comments and state whether it supports or contradicts informa-
tion derived from the meta-analyses.
Subgroup analysis and investigation of heterogeneity
We planned to carry out the following subgroup analyses.
1. People with different anaesthetic risk (ASA I (a healthy
person) or II (a person with mild systemic disease) vs ASA III or
greater (a person with severe systemic disease or worse)).
2. Different body mass index (BMI) (healthy weight (BMI
18.5 to 25) vs overweight or obese (BMI ≥ 25)).
3. Use of fibrin sealants versus no use of fibrin sealants.
4. Stapler closure versus suture closure of pancreatic stump.
We used all primary outcomes in the subgroup analyses.
We planned to use the formal Chi2 test for subgroup differences
to test for subgroup interactions.
Sensitivity analysis
Weplanned to perform sensitivity analysis defined a priori to assess
the robustness of our conclusions by:
1. excluding trials at unclear or high risk of bias (≥ 1 risk of
bias domain (other than blinding of surgeon) classified as unclear
or high);
2. excluding trials in which either mean or standard deviation
or both are imputed;
3. excluding cluster RCTs in which adjusted effect estimates
are not reported; and
4. using different methods of dealing with multi-arm trials
(see Measures of treatment effect).
Reaching conclusions
We based our conclusions only on findings from the quantita-
tive or narrative synthesis of studies included in this review. We
avoided making recommendations for practice and believe that
our implications for research will give the reader a clear sense of
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where the focus of any future research in the area should be and
will reveal remaining uncertainties.
R E S U L T S
Description of studies
Results of the search
We identified 2340 references through electronic searches of The
Cochrane Library (Wiley) (n = 1),MEDLINE (OvidSP) (n = 650),
EMBASE (OvidSP) (n = 1382), Science Citation Index Expanded
(n = 488), ClinicalTrials.gov (n = 2) and the World Health Or-
ganization (WHO) Trials Register (n = 7). After duplicate refer-
ences were removed, 1596 references remained.We excluded 1505
clearly irrelevant references by reading the abstracts. We retrieved
from the full publication a total of 91 references for further de-
tailed assessment. We excluded 76 references (62 studies) for the
reasons listed in the Characteristics of excluded studies table. Fif-
teen references reporting 12 non-randomised studies fulfilled the
inclusion criteria (Characteristics of included studies). The refer-
ence flow is shown in Figure 1.
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Figure 1. Study flow diagram.
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Included studies
We included a total of 12 non-randomised studies (Braga 2015;
Ceppa 2013; Dancea 2012; Hu 2014; Kooby 2010; Lee 2015;
Rehman 2014; Sharpe 2015; Shin 2015; Stauffer 2015; Vijan
2010; Zhang 2014). All 12 were retrospective studies (Braga 2015;
Ceppa 2013; Dancea 2012; Hu 2014; Kooby 2010; Lee 2015;
Rehman 2014; Sharpe 2015; Shin 2015; Stauffer 2015; Vijan
2010; Zhang 2014). Nine studies were single institutional studies
(Ceppa 2013; Dancea 2012; Hu 2014; Lee 2015; Rehman 2014;
Shin 2015; Stauffer 2015; Vijan 2010; Zhang 2014). Two were
multi-centre studies (Kooby 2010; Sharpe 2015). It was not clear
whether one study was a single-centre or a multi-centre study
(Braga 2015). Nine were cohort studies (Ceppa 2013; Dancea
2012; Hu 2014; Lee 2015; Rehman 2014; Sharpe 2015; Shin
2015; Stauffer 2015; Zhang 2014), and the remaining three were
case-control studies (Braga 2015; Kooby 2010; Vijan 2010).
Only one study reported ASA status (Shin 2015). Most partici-
pants in this study belonged to ASA I and II. Only one participant
with ASA IV was included in this study (Shin 2015). This study
did not report outcome data separately by ASA status. None of the
studies reported individuals with healthyweight versus overweight
or obese participants. Fibrin sealant was not used routinely, or its
use was not reported in any of the studies. Two studies routinely
used stapler closure (Shin 2015; Zhang 2014). Information on
stapler use was not available for the remaining studies.
Investigators in four studies used four ports to perform laparo-
scopic distal pancreatectomy (Hu 2014; Rehman 2014; Vijan
2010; Zhang 2014). Information on the number of ports was
not available for the remaining studies. Four studies included par-
ticipants who underwent distal pancreatectomy with or without
splenectomy (Braga 2015; Hu 2014; Vijan 2010; Zhang 2014).
The remaining studies did not state whether they included partic-
ipants who underwent distal pancreatectomy with splenectomy.
Two studies routinely placed one or more drains (Braga 2015; Hu
2014). One study reported selective drain use (Vijan 2010). Infor-
mation on drain use was not available for the remaining studies.
The 12 studies included a total of 1593 participants. One study
excluded 17 patients (metastatic disease (n = 12) and conversion to
open procedure (n = 5)) (Shin 2015). After these 17 patients were
excluded, a total of 1576 participants underwent laparoscopic dis-
tal pancreatectomy (n = 394) or open distal pancreatectomy (n
= 1182). One study did not report any outcomes of interest for
this review (Stauffer 2015). Upon exclusion of this study, a to-
tal of 1506 participants undergoing laparoscopic distal pancrea-
tectomy (353 participants) or open distal pancreatectomy (1153
participants) contributed to one or more outcomes in this review.
Mean or median age ranged from 50 years to 66 years in the five
studies that reported this information (Hu 2014; Kooby 2010;
Rehman 2014; Sharpe 2015; Shin 2015). The average proportion
of females ranged from 36.7% to 72.7% in the four studies that
reported this outcome (Hu 2014; Kooby 2010; Rehman 2014;
Shin 2015).
The average follow-up period was one month in one study (Braga
2015). In another study, the follow-up periodwas 12 to 72months
(range) (Hu 2014). Information on the follow-up period was not
available for the remaining studies.
Outcomes reported in these studies are summarised in
Characteristics of included studies.
Data were available for the entire cohort of participants who un-
derwent laparoscopic and open distal pancreatectomy and for
those who underwent laparoscopic distal pancreatectomy versus
matched controls of open distal pancreatectomy in one study
(Kooby 2010). We used data from the matched control analysis
because long-term mortality was available for this analysis only.
Excluded studies
We excluded 38 studies because separate data on patients with
pancreatic cancer were not provided Abu Hilal 2012; Baker 2011;
Baker 2013; Barrie 2014; Belli 2012; Cao 2014; Cheek 2014;
Cho 2011; de Rooij 2015; DiNorcia 2010; Duran 2014; Durlik
2013; Ejaz 2014; Eom 2008; Ferrara 2014; Finan 2009; Fox 2012;
Jayaraman 2010; Jeon 2014; Kang 2010; Kooby 2008; Lee 2014;
Limongelli 2012; Magge 2013; Malde 2012; Matejak-Gorska
2013; Mehta 2012; Nakamura 2009; Pieretti-Vanmarcke 2014;
Rooij 2014; Rosales-Velderrain 2012; Sherwinter 2012; Soh 2012;
Stauffer 2013; Tseng 2011; Velanovich 2006; Zhao 2010; Zibari
2014). We excluded nine studies because they excluded patients
with benign or premalignant disease (Butturini 2011; Casadei
2010; Chen 2012; Chung 2014; Gumbs 2008;Matsumoto 2008;
Morikawa 2012; Sahay 2011; Slepavicius 2014). We excluded
seven studies because the indication for surgery was not stated
(Kausar 2010; Liao 2014; Newman 2010; Parikh 2015; Stauffer
2012; Vicente 2013; Yoon 2012). Two studies did not include
open distal pancreatectomy as control (Daouadi 2011; Tang
2007). One study did not include distal pancreatectomy (Langan
2014). We excluded five studies because they were reviews or pro-
vided comments (Ahmed 2015; Limongelli 2014; Mehrabi 2015;
Nigri 2011; Ricci 2015).
Risk of bias in included studies
Bias due to confounding
Risk of bias due to confounding was critical in five studies (Ceppa
2013; Lee 2015; Rehman 2014; Sharpe 2015; Shin 2015) because
the open distal pancreatectomy group had more extensive cancer.
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Risk of bias due to confounding was ’no information’ for the seven
remaining studies (Braga 2015; Dancea 2012; Hu 2014; Kooby
2010; Stauffer 2015; Vijan 2010; Zhang 2014). Although some
studies reported no baseline differences between groups, these
studies were not powered to measure baseline differences.
Bias due to selection of participants
In three studies, the decision to perform laparoscopic distal pan-
createctomy or open distal pancreatectomy was based on surgeon
preference (Ceppa 2013; Lee 2015; Rehman 2014). In two stud-
ies, the decision to perform laparoscopic distal pancreatectomy or
open distal pancreatectomy was based on participant preference
(Hu 2014; Shin 2015). One study excluded patients who under-
went conversion to open surgery despite meeting inclusion criteria
(Shin 2015). This study was considered to be at critical risk of
bias related to selection of participants. Risk of bias was ’no infor-
mation’ for the remaining four of the five studies for which deci-
sions to perform laparoscopic distal pancreatectomy or open distal
pancreatectomy were based on surgeon or participant preference
(Ceppa 2013; Hu 2014; Lee 2015; Rehman 2014). The criteria
used to perform laparoscopic or open distal pancreatectomy were
not stated in the remaining studies (Braga 2015; Dancea 2012;
Kooby 2010; Sharpe 2015; Stauffer 2015; Vijan 2010; Zhang
2014), so risk of bias remains ’no information’ in these studies.
Bias due to departures from intended intervention
Three studies were at moderate risk of bias; study authors replied
that no differences were noted in postoperative management of
participants (Ceppa 2013; Kooby 2010; Lee 2015). None of the
remaining studies reported whether participant care other than
laparoscopic or open procedure was identical in the two groups.
These studies were classified as ’no information’.
Bias in measurement of outcomes
Three study authors replied that outcome assessors were not
blinded (Ceppa 2013; Kooby 2010; Lee 2015). This might have
introduced bias in measurement of outcomes other than mortal-
ity. So we classified these studies as ’no information’. Risk of bias
was classified as ’no information’ for the remaining studies because
information on outcome assessor blinding was not reported.
Bias due to missing data
Two studies were at low risk of bias; all eligible participants were
included in the study (Ceppa 2013), and a clear participant flow
indicated that all participantswhounderwent laparoscopic or open
distal pancreatectomy were included (Hu 2014). Two studies were
at critical risk of bias because participants who underwent conver-
sion to open surgery were excluded despite meeting inclusion cri-
teria (Shin 2015), or because some participants in the open group
were not matched for the laparoscopic group (Kooby 2010). It was
not clear whether any participants were excluded from analysis in
the remaining studies. Therefore, we classified these studies as ’no
information’.
Bias in selection of reported findings
Four studies reported mortality and morbidity adequately and can
be considered at low risk of bias for selective outcome reporting (
Ceppa 2013;Hu2014;Rehman2014; Shin 2015). The remaining
studies were considered to be at serious or critical risk of bias
depending upon whether they did not report morbidity alone,
or whether they did not report both mortality and morbidity,
because one would expect that studies comparing laparoscopic
distal pancreatectomy versus open distal pancreatectomy would
report data on mortality and morbidity in a detailed manner.
Effects of interventions
See: Summary of findings for the main comparison
Laparoscopic distal pancreatectomy compared with open distal
pancreatectomy for pancreatic cancer; Summary of findings 2
Laparoscopic distal pancreatectomy compared with open distal
pancreatectomy for pancreatic cancer
The effect of intervention is summarised in Summary of findings
for the main comparison and Summary of findings 2.
Mortality
Nine studies reported short-termmortality (perioperative mortal-
ity) (Braga 2015; Ceppa 2013; Hu 2014; Kooby 2010; Lee 2015;
Rehman 2014; Sharpe 2015; Shin 2015; Zhang 2014). Investiga-
tors reported no statistically significant differences in short-term
mortality between the two groups (laparoscopic group: 1/329 (ad-
justed proportion based on meta-analysis estimate: 0.5%) vs open
group: 11/1122 (1%); OR 0.48, 95% CI 0.11 to 2.17; 1451 par-
ticipants; nine studies; I2 = 0%) (Analysis 1.1). A random-effects
meta-analysis revealed no change in results.
Three studies reported long-term mortality (Hu 2014; Kooby
2010; Shin 2015). Three-year mortality was between 44% and
75% in these studies (Hu 2014; Kooby 2010; Shin 2015). Re-
searchers noted no statistically significant differences in long-term
mortality between the two groups (HR 0.96, 95% CI 0.82 to
1.12; 277 participants; three studies; I2 = 0%) (Analysis 1.2). A
random-effects meta-analysis revealed no change in results.
Serious adverse events
Three studies reported the proportions of participants with seri-
ous adverse events (Hu 2014; Rehman 2014; Shin 2015). One
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study reported no serious adverse events (Hu 2014). Serious ad-
verse events in the other studies included complications that re-
quired radiological or surgical re-intervention and grade III pan-
creatic fistula (Rehman 2014; Shin 2015). Investigators reported
no statistically significant differences in the proportions of people
with serious adverse events between the laparoscopic group (7/89:
adjusted proportion: 8.8%) and the open group (6/117: 5.1%)
(OR 1.79, 95% CI 0.53 to 6.06; 206 participants; three studies;
I2 = 0%) (Analysis 1.3). A random-effects meta-analysis revealed
no change in results.
Pancreatic fistula
Four studies reported the proportions of participants with clin-
ically significant pancreatic fistula (grade B or C) (Ceppa 2013;
Hu 2014; Rehman 2014; Shin 2015). Researchers noted no sta-
tistically significant differences in the proportions of people with
pancreatic fistula between the laparoscopic group (9/109: adjusted
proportion: 7.7%) and the open group (9/137: 6.6%) (OR 1.19,
95% CI 0.47 to 3.02; 246 participants; four studies; I2 = 61%)
(Analysis 1.4). The I2 statistic and visual inspection of forest plots
provided evidence of heterogeneity, i.e. lack of overlap of confi-
dence intervals. However, the Chi2 test for heterogeneity was not
statistically significant (P value = 0.08). A random-effects meta-
analysis revealed no change in results.
Quality of life
None of the studies reported quality of life at any point in time.
Recurrence
None of the studies reported recurrence within six months. Two
studies reported recurrence at maximal follow-up (Hu 2014; Shin
2015). In one study, two participants (18%) in the laparoscopic
group versus 11 participants (48%) in the open group had recur-
rence at maximal follow-up of 12 to 72 months (Hu 2014). In an-
other study, 35participants (49%) in the laparoscopic group versus
48 participants (60%) in the open group had recurrence at maxi-
mal follow-up (follow-up period not stated) (Shin 2015). Details
were insufficient to permit calculation of the hazard ratio for re-
currence. So we calculated the odds ratio of recurrence at maximal
follow-up. Results showed no statistically significant differences
between groups (laparoscopic group: 37/81 (adjusted proportion
based on meta-analysis estimate: 36.3%) vs open group: 59/103
(49.5%); OR 0.58, 95% CI 0.32 to 1.05; 184 participants; two
studies; I2 = 13%) (Analysis 1.5). A random-effects meta-analysis
revealed no change in results.
Adverse events
Four studies reported the proportions of participants with adverse
events of any severity (Ceppa 2013;Hu 2014; Rehman 2014; Shin
2015). Researchers reported no statistically significant differences
in the proportions of people with adverse events between the la-
paroscopic group (33/109: adjusted proportion: 31.7%) and the
open group (45/137: 32.8%) (OR 0.95, 95% CI 0.54 to 1.66;
246 participants; four studies; I2 = 18%) (Analysis 1.6). A ran-
dom-effects meta-analysis revealed no change in results.
Measures of earlier postoperative recovery
Five studies reported length of hospital stay (Hu 2014; Kooby
2010; Rehman 2014; Sharpe 2015; Shin 2015). The median of
mean lengths of hospital stay in these studies was 9.4 days in the
open distal pancreatectomy group. Mean length of hospital stay
was statistically significantly shorter in the laparoscopic group than
in the open group (MD -2.43 days, 95% CI -3.13 to -1.73; 1068
participants; five studies; I2 = 0%) (Analysis 1.7). We imputed
mean and SD from median and P value for length of hospital stay
for two studies (Rehman 2014; Shin 2015). No change in results
occurred when we excluded these two studies (MD -2.25 days,
95% CI -3.03 to -1.47; 896 participants; three studies; I2 = 0%)
(Analysis 3.1). A random-effects meta-analysis revealed no change
in results.
No studies reported any of the other measures of earlier postop-
erative recovery such as return to normal activity and return to
work.
Blood transfusion requirements
None of the studies reported blood transfusion requirements.
Positive resection margins
Ten studies reported the proportions of participants with positive
resection margins (Braga 2015; Dancea 2012; Hu 2014; Kooby
2010; Lee 2015; Rehman 2014; Sharpe 2015; Shin 2015; Vijan
2010; Zhang 2014). The fixed-effect model revealed a statistically
significantly lower proportion of people with positive resection
margins between the two groups (laparoscopic group: 49/333 (ad-
justed proportion: 14.3%) vs open group: 208/1133 (18.4%); OR
0.69, 95% CI 0.48 to 1.00; 1466 participants; 10 studies; I2 =
6%) (Analysis 1.8). The random-effects model revealed no statis-
tically significant differences between groups in the proportions
of people with positive resection margins (OR 0.74, 95% CI 0.49
to 1.10).
Assessment of reporting biases
We assessed reporting bias only for the positive resections margin
because this was the only outcome included in 10 trials. We found
no evidence of reporting bias upon visualisation of the funnel plot
and completion of Egger’s test (P value = 0.9798).
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Subgroup analysis
Stapler closure
Stapler closure was standard procedure in two studies (Shin 2015;
Zhang 2014). The remaining studies did not report whether sta-
pler closure was performed or did not report outcome data sep-
arately for stapler closure. We found no change in the results of
short-term mortality, long-term mortality, proportions of people
with serious adverse events or clinically significant pancreatic fis-
tula in this subgroup as compared with themain analysis (Analysis
2.1; Analysis 2.2; Analysis 2.3; Analysis 2.4).
We examined no other subgroups. So we were not able to use the
formal Chi2 test for differences in subgroup interactions.
Other subgroup analyses
We were not able to perform subgroup analyses of different anaes-
thetic risks or weights or fibrin sealants because the studies did not
report this information or did not report outcome data separately
for different categories.
Sensitivity analysis
We performed no other planned sensitivity analysis other than
exclusion of studies in which standard deviation was calculated
from the P value because no studies were at low risk of bias and
we identified no cluster RCTs.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Laparoscopic distal pancreatectomy compared with open distal pancreatectomy for pancreatic cancer
Patient or population: patients with pancreatic cancer
Settings: secondary or tertiary care centre
Intervention: laparoscopic distal pancreatectomy
Comparison: open distal pancreatectomy
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Quality of the evidence
(GRADE)
Assumed risk Corresponding risk
Open distal pancreatectomy Laparoscopic distal pancre-
atectomy
Recurrence at maximal fol-
low-up
495 per 1000 363 per 1000
(239 to 507)
OR 0.58
(0.32 to 1.05)
184
(2 studies)
⊕©©©
Very lowa,b,c
Adverse events (proportion) 328 per 1000 317 per 1000
(209 to 448)
OR 0.95
(0.54 to 1.66)
246
(4 studies)
⊕©©©
Very lowa,b,c
Length of hospital stay Mean length of hospital stay in
the control groups was
9.4 days
Mean length of hospital stay in
the intervention groups was
2.43 lower
(3.13 to 1.73 lower)
1068
(5 studies)
⊕©©©
Very lowa
Positive resection margins 184 per 1000 143 per 1000
(99 to 198)
OR 0.74
(0.49 to 1.10)
1466
(10 studies)
⊕©©©
Very lowa,b
None of the studies reported perioperative transfusion requirements, time to return to normal activity or time to return to work
*The basis for the assumed risk is the mean control group proportion. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and
the relative effect of the intervention (and its 95% CI)
CI: confidence interval; OR: odds ratio
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate
Very low quality: We are very uncertain about the estimate
aWe found no randomised controlled trials. The non-randomised studies included in this review were at unclear or high risk of bias for
most domains
bConfidence intervals were wide
cSample size was small
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D I S C U S S I O N
Summary of main results
In this systematic review, we compared the benefits and harms
of laparoscopic versus open distal pancreatectomy. We found no
randomised controlled trials (RCTs) on this topic. We included in
this review 12 observational studies that compared laparoscopic
versus open distal pancreatectomy; 11 studies (1506 participants:
394 underwent laparoscopic distal pancreatectomy and 1182 open
distal pancreatectomy) provided information for one or more out-
comes. People with less extensive cancer underwent laparoscopic
distal pancreatectomy, and those with more extensive cancer un-
derwent open distal pancreatectomy in some studies (Ceppa 2013;
Rehman 2014; Sharpe 2015). We found no statistically signifi-
cant differences between laparoscopic and open distal pancreatec-
tomy in terms of short-term mortality, long-term mortality, pro-
portions of participants with serious adverse events, pancreatic fis-
tula (grade B or C), recurrence at maximal follow-up, proportions
of participants with any adverse events and proportions of peo-
ple with positive resection margins. None of the studies reported
quality of life, short-term recurrence, proportions of participants
requiring blood transfusion, time to return to normal activity (re-
turn to preoperative mobility with no additional carer support)
or time to return to work. Mean length of hospital stay was 2.4
days shorter in the laparoscopic distal pancreatectomy group than
in the open distal pancreatectomy group. For other surgeries, la-
paroscopic procedures have been shown to be advantageous over
open procedures in terms of fewer complications, shorter hospital
stay or both (Bijen 2009; Keus 2006; Reza 2006; Walsh 2009). So
the reduction in hospital stay may be due to quicker postoperative
recovery resulting from the minimally invasive nature of laparo-
scopic surgery. It may also be due to bias to confounding, as people
with less extensive cancer received laparoscopic distal pancreatec-
tomy and those with more extensive cancer underwent open distal
pancreatectomy. Differences in length of hospital stay are impor-
tant only if laparoscopic distal pancreatectomy provides equiva-
lent cancer clearance as open distal pancreatectomy. Although the
confidence intervals were relatively narrow for long-term mortal-
ity, it is not possible to conclude that laparoscopic distal pancrea-
tectomy provides cancer clearance equivalent to that of open distal
pancreatectomy because of bias due to confounding, as discussed
in the Quality of the evidence section. In addition to bias, the rel-
atively small sample size for most outcomes makes study findings
unreliable on the basis of random error.
Overall completeness and applicability of
evidence
The studies included in this review examined ductal adenocarci-
noma of the distal pancreas and different stages (I to III) of pan-
creatic cancer. Hence, the findings of this review are applicable
only to distal pancreatic ductal adenocarcinomas that are amenable
to potentially curative surgery. One study clearly mentioned that
investigators included participants classified as American Society
of Anesthesiologists (ASA) stage I to IV (Shin 2015). Remaining
studies did not state the ASA status of participants. In any case, all
included studies examined only participants who could withstand
major surgery. Hence, the findings of this review are applicable
only to patients who can withstand major surgery.
Quality of the evidence
The overall quality of evidence was very low. Major reasons for
this were that the studies were observational; consequently, the
risk of confounding bias was unclear or high. Studies did not
report baseline differences for all confounding factors, and the
sample size was not sufficient to reveal differences in confounding
factors. Even if the sample size was large and all confounding
factors were reported, one cannot rule out the problem of residual
confounding. It is not clear whether this would have introduced
bias into the results.
In three studies, the decision to perform laparoscopic distal pan-
createctomy or open distal pancreatectomy was based on surgeon
preference (Ceppa 2013; Lee 2015; Rehman 2014). In two stud-
ies, the decision to perform laparoscopic distal pancreatectomy or
open distal pancreatectomy was based on participant preference
(Hu 2014; Shin 2015). Surgeon preference could be the result of
the surgeon’s experience with either technique, which one study
author reported in the reply (Lee 2015). Also, it is quite possi-
ble that participants with less extensive cancer were operated la-
paroscopically or were given the choice between laparoscopic and
open distal pancreatectomy, and those with more extensive cancer
were operated by open surgery. Open distal pancreatectomy was
associated with greater tumour size, lymph node sampling and the
presence of lymph node metastasis in one study (Ceppa 2013). In
another study, participants with large tumours (> 10 cm) consid-
ered difficult to mobilise laparoscopically were reserved for open
resections (Rehman 2014). In a third study, more participants in
the open group received neoadjuvant chemotherapy or radiation
and had larger tumours (Sharpe 2015). All of these factors are
associated with more advanced disease. This suggests that partici-
pants with more advanced disease had open distal pancreatectomy
and those with less advanced disease underwent laparoscopic distal
pancreatectomy.
Unless RCTs ensure that the same types of participants receive
laparoscopic and open distal pancreatectomy, one cannot present
reliable conclusions on the safety and effectiveness of laparoscopic
versus open distal pancreatectomy because of residual confound-
ing. In terms of other types of bias, many outcomes were subjec-
tive, and the retrospective nature of most of the studies means that
blinding of outcome assessors is extremely unlikely, even though
we have classified this risk as unclear because such information
was not provided in the study reports. This may also introduce
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bias. Complications were not reported adequately in most studies,
leading to selective outcome reporting bias.
Another factor that decreased the quality of evidence was the small
sample size resulting in wide confidence intervals for many out-
comes. Future studies should be adequately powered to measure
differences in clinically important outcomes. Heterogeneity was
not significant in the effect estimates for most outcomes despite
differences in study design.
Potential biases in the review process
We planned to include only RCTs in this review. However, in the
absence of any RCTs, we have reported the best available evidence
on this topic. We removed the RCT filter to ensure that observa-
tional studies were not removed by electronic filters. Two review
authors independently selected studies with no language restric-
tions and extracted data, decreasing potential errors in study se-
lection and data extraction. However, this is a systematic review
of non-randomised studies. Mandatory registration was not re-
quired; therefore, studies showing that laparoscopic distal pancre-
atectomy had poorer results than open distal pancreatectomy may
not have been submitted to the journals by study authors because
laparoscopic distal pancreatectomy is a new procedure compared
with the established treatment of open distal pancreatectomy. So
we cannot rule out publication bias.
We imputedmean and calculated standard deviation frommedian
and P values for length of hospital stay in two studies (Rehman
2014; Shin 2015). Exclusion of these two studies did not alter
effect estimates for length of hospital stay, suggesting that this im-
putation of mean and calculation of standard deviation are un-
likely to result in bias. We calculated the hazard ratio for long-term
mortality using methods suggested by Parmar et al (Parmar 1998),
which assume constant proportional hazards. Kaplan-Meier curves
in these studies indicated that proportional hazards appeared con-
stant.
Agreements and disagreements with other
studies or reviews
This is the first systematic review on laparoscopic distal pancrea-
tectomy versus open distal pancreatectomy with specific reference
to pancreatic cancer. Seven study authors concluded that laparo-
scopic distal pancreatectomy is a safe and feasible surgical modal-
ity (Ceppa 2013; Hu 2014; Lee 2015; Rehman 2014; Sharpe
2015; Shin 2015; Zhang 2014). Four study authors suggested that
laparoscopic distal pancreatectomy offers equivalent oncological
outcomes (Hu 2014; Lee 2015; Rehman 2014; Sharpe 2015). De-
spite the statement made by one of the study authors that a ran-
domised controlled trial comparing cancer outcomes for laparo-
scopic and open distal pancreatectomy for pancreatic ductal ade-
nocarcinoma is likely to fail because of the small target patient
population that would satisfy the criteria for enrolment (Kooby
2010), we agree with three study authors that a randomised con-
trolled trial is necessary to assess the role of laparoscopic surgery in
the treatment of people undergoing distal pancreatectomy (Ceppa
2013; Hu 2014; Rehman 2014).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Currently, no randomised controlled trials have compared laparo-
scopic distal pancreatectomy versus open distal pancreatectomy
for patients with pancreatic cancer. In observational studies, la-
paroscopic distal pancreatectomy is associated with shorter hospi-
tal stay as compared with open distal pancreatectomy. However,
this association is unlikely to be causal. Currently no available in-
formation has revealed a causal association in the differences be-
tween laparoscopic versus open distal pancreatectomy.
Implications for research
Future studies should try to address as many issues mentioned
below as possible. The rationale for the study design is mentioned
alongside.
Study design: randomised controlled trial (only a randomised con-
trolled trial can establish a causal association in this situation).
Participants: people with potentially resectable distal pancreatic
cancer (stages I and II adenocarcinoma of the pancreas) fit to un-
dergo major surgery. Alternatively, people undergoing distal pan-
createctomy for benign or malignant pancreatic disease but strat-
ified according to benign or malignant pancreatic lesions.
Intervention: laparoscopic distal pancreatectomy.
Control: open distal pancreatectomy.
Outcomes: important patient-oriented measures such as short-
termmortality and long-termmortality (at least two to three years),
health-related quality of life, complications and the sequelae of
complications, resectionmargins,measures of earlier postoperative
recovery such as length of hospital stay, time to return to normal
activity and time to return to work (for those who are employed)
and recurrence of cancer. In addition, information on resource use
can be collected if the purpose was cost-effectiveness in addition
to effectiveness.
Two to three years of follow-up has been suggested because three-
year mortality was between 44% and 75% in these studies (Hu
2014; Kooby 2010; Shin 2015) .
Other aspects of study design:
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• observer-blinded randomised controlled trial: to control for
selection bias and detection bias;
• identical care apart from laparoscopic versus open distal
pancreatectomy: to control for performance bias; and
• inclusion of all participants in the analysis and performance
of an intention-to-treat analysis: to control for attrition bias.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Braga 2015
Methods Study design: case-control study with propensity score matching
Participants Country: Italy
Number eligible: 64
Number excluded: not stated
Number analysed: 64
Average age: not stated
Females: not stated
ASA I or II: not stated
ASA III or IV: not stated
Stapler closure: not stated
Fibrin sealant: not stated
Mean BMI: not stated
Study setting: not clear
Period of recruitment: 2010 to 2013
Follow-up in months: 1
Inclusion criteria
Patients with pancreatic cancer (adenocarcinoma) undergoing distal pancreatectomy
Note: The study included patients without pancreatic adenocarcinoma who were ex-
cluded from the analysis
Exclusion criteria
1. Borderline resectable cancer
2. Cardiovascular dysfunction
3. Respiratory dysfunction
4. BMI > 35
5. Refusal to consent to laparoscopy
Interventions Group 1: laparoscopic distal pancreatectomy (n = 30)
Further details: number of ports: not stated; with or without splenectomy; 1 drain placed
routinely
Group 2: open distal pancreatectomy (n = 34)
Further details: not stated
Outcomes Outcomes reported were mortality and resection margins
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Bias due to confounding Unclear risk No information
Comment: Study authors used propensity
score matching for matching laparoscopic
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Braga 2015 (Continued)
and open groups. Although the presence
of malignancy was considered a factor in
the matching, the size of the tumour and
involvement of adjacent structureswere not
considered in the matching
Bias due to selection of participants to in-
tervention and control
Unclear risk No information
Comment: It was not clear whether eligible
patients were excluded from the report
Bias due to differences in co-interventions
which were different between the groups
Unclear risk No information
Comment: This information was not avail-
able
Bias in the measurement of outcomes Unclear risk No information
Comment: This information was not avail-
able
Bias due to missing data Unclear risk No information
Comment: This information was not avail-
able
Bias in selection of the reported findings High risk Serious risk of bias
Comment: Complications were not re-
ported in participants with pancreatic can-
cer
Ceppa 2013
Methods Study design: retrospective cohort study
Participants Country: USA
Number eligible: 40
Number excluded: not stated
Number analysed: 40
Average age: not stated
Females: not stated
ASA I or II: not stated
ASA III or IV: not stated
Stapler closure: not stated
Fibrin sealant: not stated
Mean BMI: not stated
Study setting: single centre; Indiana University School of Medicine, Indianapolis, USA
Period of recruitment: 2005 to 2012
Follow-up in months: not stated
Inclusion criteria
Patients with pancreatic adenocarcinoma undergoing distal pancreatectomy
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Ceppa 2013 (Continued)
Interventions Group 1: laparoscopic distal pancreatectomy (n = 20)
Further details: not stated
Group 2: open distal pancreatectomy (n = 20)
Further details: not stated
The choice of laparoscopic vs open method was based on surgeon preference
Outcomes Outcomes reported were short-term mortality and complications
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Bias due to confounding High risk Critical risk of bias
Quote: “Open DP was associated with
greater tumor size (4.3 +/- 0.4 cm vs. 2.9 +/-
0.3 cm), lymph node sampling (18 +/- 2 vs.
13 +/- 2) and presence of lymph node metas-
tasis (80% vs. 25%)”
Comment: Participants undergoing open
distal pancreatectomy had more extensive
cancer
Bias due to selection of participants to in-
tervention and control
Low risk Moderate risk of bias
Comment: All eligible participants were in-
cluded
Bias due to differences in co-interventions
which were different between the groups
Low risk Moderate risk of bias
Quote: “The postoperative care for these pa-
tients was and is identical. So no differences
in how the patients are managed postopera-
tively (author replies)”
Bias in the measurement of outcomes High risk Critical risk of bias
Quote: “the assessors were not blinded (au-
thor replies)”
Bias due to missing data Low risk Low risk of bias
Comment: Participants with pancreatic can-
cer who underwent distal pancreatectomy
were not excluded from the analysis (author
replies)
Bias in selection of the reported findings Low risk Low risk of bias
Comment: Mortality and complications
were reported
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Dancea 2012
Methods Study design: retrospective cohort study
Participants Country: USA
Number eligible: 14
Number excluded: not stated
Number analysed: 14
Average age: not stated
Females: not stated
ASA I or II: not stated
ASA III or IV: not stated
Stapler closure: not stated
Fibrin sealant: not stated
Mean BMI: not stated
Study setting: single centre; Geisinger Medical Center, Danville, USA
Period of recruitment: 1999 to 2011
Follow-up in months: not stated
Inclusion criteria
Patients with pancreatic malignancy undergoing distal pancreatectomy
Notes: The study included patients without pancreatic malignancy who were excluded
from the analysis
Interventions Group 1: laparoscopic distal pancreatectomy (n = 4)
Further details: not stated
Group 2: open distal pancreatectomy (n = 10)
Further details: not stated
Outcomes The outcome reported was resection margins
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Bias due to confounding Unclear risk No information
Comment: This information was not avail-
able
Bias due to selection of participants to in-
tervention and control
Unclear risk No information
Comment: It was not clear whether eligible
participants were excluded from the report
Bias due to differences in co-interventions
which were different between the groups
Unclear risk No information
Comment: This information was not avail-
able
Bias in the measurement of outcomes Unclear risk No information
Comment: This information was not avail-
able
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Dancea 2012 (Continued)
Bias due to missing data Unclear risk No information
Comment: This information was not avail-
able
Bias in selection of the reported findings High risk Critical risk of bias
Comment: Mortality and complications
were not reported
Hu 2014
Methods Study design: retrospective cohort study
Participants Country: China
Number eligible: 34
Number excluded: not stated
Number analysed: 34
Average age: 50 years
Females: 14 (41.2%)
ASA I or II: not stated
ASA III or IV: not stated
Stapler closure: not stated
Fibrin sealant: not stated
Mean BMI: not stated
Study setting: single centre; The General Hospital of Chinese People’s Liberation Army,
Beijing, China
Period of recruitment: 2007 to 2011
Follow-up in months: 12 to 72 (range)
Inclusion criteria
1. Patients with resectable distal pancreatic cancer undergoing distal pancreatectomy
2. Tumour size < 4 cm
Exclusion criteria
1. Involvement of the superior mesenteric artery
2. Requirement for an extended resection
3. Previous history of upper abdominal surgery
4. Serious cardiopulmonary or hepatorenal insufficiency
Interventions Group 1: laparoscopic distal pancreatectomy (n = 11)
Further details: 4 ports; with or without splenectomy; 2 drains were placed
Group 2: open distal pancreatectomy (n = 23)
Further details: not stated
The choice of laparoscopic or open method was made at the sole discretion of the
participant
Outcomes Outcomes reported were short-term and long-term mortality, complications, operating
time, length of hospital stay, recurrence at maximal follow-up
Notes Adjuvant treatment: Two-cycle gemcitabine was given 1 month after distal pancreatec-
tomy
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Hu 2014 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Bias due to confounding Unclear risk No information
Quote: “The choice of either technique was
at the sole discretion of the patient....... The
two groups were comparable in terms of
age, sex, body mass index, American Society
of Anesthesiology classification, Eastern Co-
operative Oncology Group grading, tumor
size, location and staging, CA 19-9 levels,
previous history of abdominal surgery, and
concomitant medical/surgical conditions (all
P[0.05))”
Comment: The sample size was small and
was not powered to identify baseline differ-
ences between groups
Bias due to selection of participants to in-
tervention and control
Unclear risk Moderate risk of bias
Comment: All eligible participants were in-
cluded
Bias due to differences in co-interventions
which were different between the groups
Unclear risk No information
Comment: This information was not avail-
able
Bias in the measurement of outcomes Unclear risk No information
Comment: This information was not avail-
able
Bias due to missing data Low risk Low risk of bias
Comment: A clear participant flow indicated
that all participants who underwent laparo-
scopic or open distal pancreatectomy were
included
Bias in selection of the reported findings Low risk Low risk of bias
Comment: Mortality and complications
were reported
Kooby 2010
Methods Study design: retrospective case-control study
Participants Country: USA
Number eligible: 93
Number excluded: not stated
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Kooby 2010 (Continued)
Number analysed: 93
Average age: 65 years
Females: 55 (59.1%)
ASA I or II: not stated
ASA III or IV: not stated
Stapler closure: not stated
Fibrin sealant: not stated
Mean BMI: 26 (28%)
Study setting: multi-centre USA; USA
Period of recruitment: 2000 to 2008
Follow-up in months: not stated
Inclusion criteria
Patients undergoing distal pancreatectomy for pancreatic cancer
Exclusion criteria
1. Adenocarcinoma with a background of intraductal papillary mucinous neoplasm or
mucinous cystadenocarcinoma
2. Insufficient demographic, operative and outcomes data available for analysis and
reporting
Interventions Group 1: laparoscopic distal pancreatectomy (n = 23)
Further details: not stated
Group 2: open distal pancreatectomy (n = 70)
Further details: not stated
Of 23 participants who underwent laparoscopic distal pancreatectomy, 4 underwent
hand access procedures and another 4 procedures had to be converted to open procedures
Outcomes Outcomes reported were long-termmortality, operating time, length of hospital stay and
positive margins
Notes Adjuvant therapy (use of preoperative or postoperative chemotherapy with or without
radiation therapy): laparoscopic distal pancreatectomy (n = 13), open distal pancreatec-
tomy (n = 45)
Risk of bias
Bias Authors’ judgement Support for judgement
Bias due to confounding Unclear risk No information
Quote: “Three factors were used to select
patients for the matched cohort compari-
son: age (years), ASA status (1 to 4), and tu-
mor size (cm)”. “We excluded patients who
needed vascular resection and other organ
resections (author replies)”
Comment: Tumours were not matched for
all known confounding factors, for exam-
ple, lymph node status, body mass index
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Kooby 2010 (Continued)
Bias due to selection of participants to in-
tervention and control
Unclear risk No information
Comment: We were not able to assess this
information because control participants
were excluded because they did not match
intervention participants
Bias due to differences in co-interventions
which were different between the groups
Low risk Moderate risk of bias
Quote: “No difference in the care between
patients apart from laparoscopic or open
approach (author replies)”
Bias in the measurement of outcomes High risk Critical risk of bias
Outcome assessors were not blinded
Quote: “..this was a retrospective study (au-
thor replies)”
Bias due to missing data High risk Critical risk of bias
Comment: Several participants were ex-
cluded because complete data were not
available, and because some participants in
the open group were not matched for the
laparoscopic group
Bias in selection of the reported findings High risk Critical risk of bias
Comment: Short-termmortality and com-
plications were not reported
Lee 2015
Methods Study design: retrospective cohort study
Participants Country: USA
Number eligible: 268
Number excluded: not stated
Number analysed: 268
Average age: not stated
Females: not stated
ASA I or II: not stated
ASA III or IV: not stated
Stapler closure: not stated
Fibrin sealant: not stated
Mean BMI: not stated
Study setting: single centre; Memorial Sloan Kettering Cancer Center, New York, USA
Period of recruitment: 2000 to 2013
Follow-up in months: not stated
Inclusion criteria
Patients with pancreatic malignancy undergoing distal pancreatectomy
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Lee 2015 (Continued)
Notes: The study included patients without pancreatic malignancy who were excluded
from the analysis
Exclusion criteria
Patients with additional organ resection
Interventions Group 1: laparoscopic distal pancreatectomy (n = 19)
Further details: not stated
Group 2: open distal pancreatectomy (n = 249)
Further details: not stated
Outcomes The outcome reported was resection margins
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Bias due to confounding High risk Critical risk of bias
Quote: “Selection was purely by individual
surgeon. Some us do more MIS, some do
more open. In the MIS group some of us
do robotics and some laparoscopy. The only
exclusion criteria is portal vein involvement
- none of us will do a case minimally invasive
if we think this may be what we find (author
replies)”
Comment: It appears that the cancer involve-
ment of adjacent tissues was greater in the
open group than in the laparoscopic group
Bias due to selection of participants to in-
tervention and control
Unclear risk No information
Comment: It was not clear whether eligible
participants were excluded from the report
Bias due to differences in co-interventions
which were different between the groups
Low risk Moderate risk of bias
Quote: “No other difference in the care - they
all follow the same general pathways (author
replies)”
Bias in the measurement of outcomes High risk Critical risk of bias
Quote: “Complications are filled into our
database prospectively, so no one is blinded
(author replies)”
Bias due to missing data Unclear risk No information
Comment: This information was not avail-
able
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Lee 2015 (Continued)
Bias in selection of the reported findings High risk Serious risk of bias
Comment: Complications were not reported
Rehman 2014
Methods Study design: retrospective cohort study
Participants Country: UK
Number eligible: 22
Number excluded: not stated
Number analysed: 22
Average age: 64 years
Females: 16 (72.7%)
ASA I or II: not stated
ASA III or IV: not stated
Stapler closure: not stated
Fibrin sealant: not stated
Mean BMI: not stated
Study setting: single centre; Freeman Hospital, Newcastle upon Tyne, UK
Period of recruitment: 2008 to 2011 (another report with a larger number of participants
was included for resection margins and operating time; the period of recruitment was
2005 to 2012)
Follow-up in months: not stated
Inclusion criteria
Patients undergoing distal pancreatectomy for pancreatic adenocarcinoma
Exclusion criteria
Patients with > 10 cm tumour were excluded in laparoscopic group and underwent open
distal pancreatectomy
Interventions Group 1: laparoscopic distal pancreatectomy (n = 8)
Further details: 4 ports; splenectomy: not stated; drains: not stated
Group 2: open distal pancreatectomy (n = 14)
Further details: not stated
The choice of laparoscopic versus open method was based on the surgeon who operated
on the participant
Outcomes Outcomes reported were short-term mortality, complications, operating time, positive
resection margins and length of hospital stay
Notes Additionally 5 participants in the laparoscopic distal pancreatectomy group and 8 in the
open distal pancreatectomy group received adjuvant chemotherapy
Significant overlap of participants was noted between the Rehman 2014 reference and
the Rehman 2013 reference. We have obtained information from the Rehman 2014
reference in full text; the Rehman 2013 reference was a conference abstract
Risk of bias
Bias Authors’ judgement Support for judgement
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Rehman 2014 (Continued)
Bias due to confounding High risk Critical risk of bias
Quote: “In general patients with large tu-
mours (> 10 cm) considered difficult to mo-
bilise laparoscopically were reserved for open
resections”
Bias due to selection of participants to in-
tervention and control
Unclear risk No information
Comment: It was not clear whether eligible
participants were excluded from the report
Bias due to differences in co-interventions
which were different between the groups
Unclear risk No information
Comment: This information was not avail-
able
Bias in the measurement of outcomes Unclear risk No information
Comment: This information was not avail-
able
Bias due to missing data Unclear risk No information
Comment: This information was not avail-
able
Bias in selection of the reported findings Low risk Low risk of bias
Comment: Mortality and complications
were reported
Sharpe 2015
Methods Study design: retrospective cohort study
Participants Country: USA
Number eligible: 769
Number excluded: not stated
Number analysed: 769
Average age: 66 years
Females: not stated
ASA I or II: not stated
ASA III or IV: not stated
Stapler closure: not stated
Fibrin sealant: not stated
Mean BMI: not stated
Study setting: National Cancer Data Base (USA) (Joint Project of the Commission on
Cancer of the American College of Surgeons and the American Cancer Society; captures
information from approximately 1500 Commission on Cancer-accredited hospitals and
more than 70% of all newly diagnosed malignancies in the United States)
Period of recruitment: 2010 and 2011
Follow-up in months: not stated
Inclusion criteria
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Sharpe 2015 (Continued)
Adults (18 years or older) undergoing distal pancreatectomy for pancreatic adenocarci-
noma
Exclusion criteria
Metastatic disease or concomitant cancer diagnosis
Interventions Group 1: laparoscopic distal pancreatectomy (n = 144)
Further details: not stated
Group 2: open distal pancreatectomy (n = 625)
Further details: not stated
Outcomes Outcomes reported were short-term mortality, resection margins and length of hospital
stay
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Bias due to confounding High risk Critical risk of bias
Quote: “More patients in the open group re-
ceived neoadjuvant chemotherapy (11% vs
2%, P < .001) or radiation (6% vs 2%, P =
.049). Patients in the open group had larger
tumours than those in the laparoscopic group
(4.2 ± 3.2 vs 3.7 ± 1.9 cm, P = .018)”
Bias due to selection of participants to in-
tervention and control
Unclear risk No information
Comment: It was not clear whether eligible
participants were excluded from the report
Bias due to differences in co-interventions
which were different between the groups
Unclear risk No information
Comment: This information was not avail-
able
Bias in the measurement of outcomes Unclear risk No information
Comment: This information was not avail-
able
Bias due to missing data Unclear risk No information
Comment: This information was not avail-
able
Bias in selection of the reported findings High risk Serious risk of bias
Comment: Complications were not reported
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Shin 2015
Methods Study design: retrospective cohort study
Participants Country: South Korea
Number eligible: 167
Number excluded: 17 (10.2%)
Number analysed: 150
Average age: 63 years
Females: 55 (36.7%)
ASA I or II: 133(88.7%)
ASA III or IV: 17 (11.3%)
Stapler closure: 150 (100%)
Fibrin sealant: not stated
Mean BMI: not stated
Study setting: single centre; Asan Medical Center, Seoul, South Korea
Period of recruitment: 2006 to 2013
Follow-up in months: not stated
Interventions Group 1: laparoscopic distal pancreatectomy (n = 70)
Further details: not stated
Group 2: open distal pancreatectomy (n = 80)
Further details: not stated
The choice of laparoscopic or open method was made at the sole discretion of the
participant
Outcomes Outcomes reported were short-term and long-termmortality, recurrence, complications,
operating time, resection margins and hospital stay
Notes Adjuvant chemotherapy: laparoscopic distal pancreatectomy (n = 55) and open distal
pancreatectomy (n = 55)
Reasons for exclusions: metastatic disease (12) and conversion to open procedure (5)
Risk of bias
Bias Authors’ judgement Support for judgement
Bias due to confounding High risk Critical risk of bias
Comment: Tumour size was smaller in la-
paroscopic group
Bias due to selection of participants to in-
tervention and control
High risk Critical risk of bias
Comment: Peoplewhomet eligibility criteria
were excluded because they underwent con-
version to open surgery
Bias due to differences in co-interventions
which were different between the groups
Unclear risk No information
Comment: This information was not avail-
able
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Shin 2015 (Continued)
Bias in the measurement of outcomes Unclear risk No information
Comment: This information was not avail-
able
Bias due to missing data High risk Critical risk of bias
Comment: Participants who met eligibility
criteria were excluded. This could have af-
fected the outcome
Bias in selection of the reported findings Low risk Low risk of bias
Comment: Mortality and complications
were reported
Stauffer 2015
Methods Study design: retrospective cohort study
Participants Country: USA
Number eligible: 70
Number excluded: not stated
Number analysed: 70
Average age: not stated
Females: not stated
ASA I or II: not stated
ASA III or IV: not stated
Stapler closure: not stated
Fibrin sealant: not stated
Mean BMI: not stated
Study setting: single centre; Mayo Clinic Florida, Jacksonville, USA
Period of recruitment: not stated
Follow-up in months: not stated
Inclusion criteria
Patients undergoing distal pancreatectomy for pancreatic adenocarcinoma
Interventions Group 1: laparoscopic distal pancreatectomy (n = 41)
Further details: not stated
Group 2: open distal pancreatectomy (n = 29)
Further details: not stated
Outcomes None of the outcomes of interest were reported
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Stauffer 2015 (Continued)
Bias due to confounding Unclear risk No information
Comment: This information was not avail-
able
Bias due to selection of participants to in-
tervention and control
Unclear risk No information
Comment: It was not clear whether eligible
participants were excluded from the report
Bias due to differences in co-interventions
which were different between the groups
Unclear risk No information
Comment: This information was not avail-
able
Bias in the measurement of outcomes Unclear risk No information
Comment: This information was not avail-
able
Bias due to missing data Unclear risk No information
Comment: This information was not avail-
able
Bias in selection of the reported findings High risk Critical risk of bias
Comment: Mortality and complications
were not reported
Vijan 2010
Methods Study design: case-control study
Participants Country: USA
Number eligible: 41
Number excluded: not stated
Number analysed: 41
Average age: not stated
Females: not stated
ASA I or II: not stated
ASA III or IV: not stated
Stapler closure: not stated
Fibrin sealant: not stated
Mean BMI: not stated
Study setting: single centre; Mayo Clinic, Rochester, USA
Period of recruitment: 2004 to 2009
Follow-up in months: not stated
Inclusion criteria
Patients with pancreatic malignancy undergoing distal pancreatectomy
Notes: The study included participants without pancreatic malignancy who were ex-
cluded from the analysis
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Vijan 2010 (Continued)
Interventions Group 1: laparoscopic distal pancreatectomy (n = 20)
Further details: 4 ports; with or without splenectomy; selective closed suction drain
Group 2: open distal pancreatectomy (n = 21)
Outcomes The outcome reported was resection margins
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Bias due to confounding Unclear risk No information
Quote: “Following institutional review board ap-
proval, 100 patients undergoing LDP were matched
by patient age (± 8 years), pathologic diagnosis (be-
nign vs malignant), and pancreatic specimen length
(± 2 cm) to a cohort (n = 100) undergoing ODP”
Comment: Matching does not take all confounding
factors into account, for example, stage of tumour
Bias due to selection of participants to in-
tervention and control
Unclear risk No information
Comment: It was not clear whether eligible partici-
pants were excluded from the report
Bias due to differences in co-interventions
which were different between the groups
Unclear risk No information
Comment: This information was not available
Bias in the measurement of outcomes Unclear risk No information
Comment: This information was not available
Bias due to missing data Unclear risk No information
Comment: This information was not available
Bias in selection of the reported findings High risk Critical risk of bias
Comment: Mortality and complications were not re-
ported
Zhang 2014
Methods Study design: retrospective cohort study
Participants Country: China
Number eligible: 11
Number excluded: not stated
Number analysed: 11
Average age: not stated
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Zhang 2014 (Continued)
Females: not stated
ASA I or II: not stated
ASA III or IV: not stated
Stapler closure: 11 (100%)
Fibrin sealant: not stated
Mean BMI: not stated
Study setting: single centre; The Third Affiliated Hospital of Soochow University,
Changzhou, China
Period of recruitment: 2009 to 2013
Follow-up in months: not stated
Inclusion criteria
Patients with pancreatic malignancy undergoing distal pancreatectomy
Notes: The study included participants without pancreatic malignancy who were ex-
cluded from the analysis
Interventions Group 1: laparoscopic distal pancreatectomy (n = 4)
Further details: 4 ports; with or without splenectomy; drain use not stated
Group 2: open distal pancreatectomy (n = 7)
Outcomes Outcomes reported were short-term mortality and resection margins
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Bias due to confounding Unclear risk No information
Comment: This information was not avail-
able
Bias due to selection of participants to in-
tervention and control
Unclear risk No information
Comment: It was not clear whether eligible
participants were excluded from the report
Bias due to differences in co-interventions
which were different between the groups
Unclear risk No information
Comment: This information was not avail-
able
Bias in the measurement of outcomes Unclear risk No information
Comment: This information was not avail-
able
Bias due to missing data Unclear risk No information
Comment: This information was not avail-
able
Bias in selection of the reported findings High risk Serious risk of bias
Comment: Complications were not reported
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Abbreviations:
ASA: American Society of Anethesiologists
BMI: body mass index
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Abu Hilal 2012 No separate data available on people with pancreatic cancer
Ahmed 2015 Review
Baker 2011 No separate data available on people with pancreatic cancer
Baker 2013 No separate data available on people with pancreatic cancer
Barrie 2014 Includes metastatic renal carcinoma
Belli 2012 No separate data available on people with pancreatic cancer
Butturini 2011 Study performed in people with benign or premalignant lesions
Cao 2014 No separate data available on people with pancreatic cancer
Casadei 2010 Study performed in people with benign or premalignant lesions
Cheek 2014 No separate data available on people with pancreatic cancer
Chen 2012 Study performed in people with benign or premalignant lesions
Cho 2011 No separate data available on people with pancreatic cancer
Chung 2014 Study performed in people with benign or premalignant lesions
Dancea 2012a No separate data available on people with pancreatic cancer
Daouadi 2011 No open distal pancreactectomy as control group
de Rooij 2015 No separate data available on people with pancreatic cancer
DiNorcia 2010 No separate data available on people with pancreatic cancer
Duran 2014 No separate data available on people with pancreatic cancer
Durlik 2013 No separate data available on people with pancreatic cancer
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(Continued)
Ejaz 2014 No separate data available on people with pancreatic cancer
Eom 2008 No separate data available on people with pancreatic cancer
Ferrara 2014 No separate data available on people with pancreatic cancer
Finan 2009 No separate data available on people with pancreatic cancer
Fox 2012 No separate data available on people with pancreatic cancer
Gumbs 2008 Study performed in people with benign or premalignant lesions
Jayaraman 2010 No separate data available on people with pancreatic cancer
Jeon 2014 No separate data available on people with pancreatic cancer
Kang 2010 No separate data available on people who underwent laparoscopic distal pancreatectomy
Kausar 2010 Indication for surgery not stated
Kooby 2008 No separate data available on people with pancreatic cancer
Langan 2014 Not on distal pancreatectomy
Lee 2014 No separate data available on people who underwent laparoscopic distal pancreatectomy
Liao 2014 Indication for surgery not stated
Limongelli 2012 No separate data available on people with pancreatic cancer
Limongelli 2014 Comment on an excluded study (Cho 2011)
Magge 2013 No separate data available on people who underwent laparoscopic distal pancreatectomy
Malde 2012 No separate data available on people with pancreatic cancer
Matejak-Gorska 2013 No separate data available on people with pancreatic cancer
Matsumoto 2008 Study performed in people with benign or premalignant lesions
Mehrabi 2015 Review
Mehta 2012 No separate data available on people with pancreatic cancer
Morikawa 2012 Study performed in people with benign lesions
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(Continued)
Nakamura 2009 No separate data available on people with pancreatic cancer
Newman 2010 Indication for surgery not stated
Nigri 2011 Review
Parikh 2015 Indication for surgery not stated
Pieretti-Vanmarcke 2014 No separate data available on people with pancreatic cancer
Ricci 2015 Review
Rooij 2014 No separate data available on people with pancreatic cancer
Rosales-Velderrain 2012 No separate data available on people with pancreatic cancer
Sahay 2011 Study performed in people with non-cancerous lesions
Sherwinter 2012 No separate data available on people with pancreatic cancer
Slepavicius 2014 Study performed in people with benign and borderline lesions
Soh 2012 No separate data available on people with pancreatic cancer
Stauffer 2012 Indication for surgery not stated
Stauffer 2013 No separate data available on people with pancreatic cancer
Tang 2007 No control group of open distal pancreatectomy
Tseng 2011 No separate data available on people with pancreatic cancer
Velanovich 2006 No separate data available on people with pancreatic cancer
Vicente 2013 Indication for surgery not stated
Yoon 2012 Indication for surgery not stated
Zhao 2010 No separate data available on people with pancreatic cancer
Zibari 2014 No separate data available on people who underwent laparoscopic distal pancreatectomy
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D A T A A N D A N A L Y S E S
Comparison 1. Laparoscopic distal pancreatectomy versus open distal pancreatectomy
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Short-term mortality 9 1451 Odds Ratio (M-H, Fixed, 95% CI) 0.48 [0.11, 2.17]
2 Long-term mortality 3 277 Hazard Ratio (Fixed, 95% CI) 0.96 [0.82, 1.12]
3 Serious adverse events
(proportion)
3 206 Odds Ratio (M-H, Fixed, 95% CI) 1.79 [0.53, 6.06]
4 Pancreatic fistula (grade B or C) 4 246 Odds Ratio (M-H, Fixed, 95% CI) 1.19 [0.47, 3.02]
5 Recurrence at maximal follow-up 2 184 Odds Ratio (M-H, Fixed, 95% CI) 0.58 [0.32, 1.05]
6 Adverse events (proportion) 4 246 Odds Ratio (M-H, Fixed, 95% CI) 0.95 [0.54, 1.66]
7 Length of hospital stay 5 1068 Mean Difference (IV, Random, 95% CI) -2.43 [-3.13, -1.73]
8 Positive resection margins 10 1466 Odds Ratio (M-H, Random, 95% CI) 0.74 [0.49, 1.10]
Comparison 2. Subgroup analysis (stapler only)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Short-term mortality 2 161 Odds Ratio (M-H, Random, 95% CI) 0.38 [0.02, 9.38]
2 Long-term mortality 1 Hazard Ratio (Fixed, 95% CI) 0.88 [0.67, 1.15]
3 Serious adverse events
(proportion)
1 150 Odds Ratio (M-H, Fixed, 95% CI) 3.0 [0.56, 15.98]
4 Pancreatic fistula (grade B or C) 1 150 Odds Ratio (M-H, Fixed, 95% CI) 3.31 [0.84, 13.01]
Comparison 3. Sensitivity analysis
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Length of hospital stay 3 896 Mean Difference (IV, Random, 95% CI) -2.25 [-3.03, -1.47]
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Analysis 1.1. Comparison 1 Laparoscopic distal pancreatectomy versus open distal pancreatectomy,
Outcome 1 Short-term mortality.
Review: Laparoscopic versus open distal pancreatectomy for pancreatic cancer
Comparison: 1 Laparoscopic distal pancreatectomy versus open distal pancreatectomy
Outcome: 1 Short-term mortality
Study or subgroup
Laparoscopic
dist pancr Open dist pancr Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Braga 2015 0/30 0/34 Not estimable
Ceppa 2013 1/20 0/20 8.0 % 3.15 [ 0.12, 82.16 ]
Hu 2014 0/11 0/23 Not estimable
Kooby 2010 0/23 0/70 Not estimable
Lee 2015 0/19 0/249 Not estimable
Rehman 2014 0/8 0/14 Not estimable
Sharpe 2015 0/144 10/625 68.0 % 0.20 [ 0.01, 3.48 ]
Shin 2015 0/70 1/80 24.0 % 0.38 [ 0.02, 9.38 ]
Zhang 2014 0/4 0/7 Not estimable
Total (95% CI) 329 1122 100.0 % 0.48 [ 0.11, 2.17 ]
Total events: 1 (Laparoscopic dist pancr), 11 (Open dist pancr)
Heterogeneity: Chi2 = 1.66, df = 2 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 0.95 (P = 0.34)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours laparoscopic Favours open
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Analysis 1.2. Comparison 1 Laparoscopic distal pancreatectomy versus open distal pancreatectomy,
Outcome 2 Long-term mortality.
Review: Laparoscopic versus open distal pancreatectomy for pancreatic cancer
Comparison: 1 Laparoscopic distal pancreatectomy versus open distal pancreatectomy
Outcome: 2 Long-term mortality
Study or subgroup
Laparoscopic
dist pancr Open dist pancr log [Hazard Ratio] Hazard Ratio Weight Hazard Ratio
N N (SE) IV,Fixed,95% CI IV,Fixed,95% CI
Hu 2014 11 23 -0.11584 (0.136025) 32.5 % 0.89 [ 0.68, 1.16 ]
Kooby 2010 23 70 0.10366 (0.129256) 35.9 % 1.11 [ 0.86, 1.43 ]
Shin 2015 70 80 -0.13174 (0.137829) 31.6 % 0.88 [ 0.67, 1.15 ]
Total (95% CI) 104 173 100.0 % 0.96 [ 0.82, 1.12 ]
Heterogeneity: Chi2 = 1.99, df = 2 (P = 0.37); I2 =0.0%
Test for overall effect: Z = 0.54 (P = 0.59)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours laparoscopic Favours open
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Analysis 1.3. Comparison 1 Laparoscopic distal pancreatectomy versus open distal pancreatectomy,
Outcome 3 Serious adverse events (proportion).
Review: Laparoscopic versus open distal pancreatectomy for pancreatic cancer
Comparison: 1 Laparoscopic distal pancreatectomy versus open distal pancreatectomy
Outcome: 3 Serious adverse events (proportion)
Study or subgroup
Laparoscopic
dist pancr Open dist pancr Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Hu 2014 0/11 0/23 Not estimable
Rehman 2014 2/8 4/14 55.7 % 0.83 [ 0.12, 6.01 ]
Shin 2015 5/70 2/80 44.3 % 3.00 [ 0.56, 15.98 ]
Total (95% CI) 89 117 100.0 % 1.79 [ 0.53, 6.06 ]
Total events: 7 (Laparoscopic dist pancr), 6 (Open dist pancr)
Heterogeneity: Chi2 = 0.94, df = 1 (P = 0.33); I2 =0.0%
Test for overall effect: Z = 0.94 (P = 0.35)
Test for subgroup differences: Not applicable
0.05 0.2 1 5 20
Favours laparoscopic Favours open
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Analysis 1.4. Comparison 1 Laparoscopic distal pancreatectomy versus open distal pancreatectomy,
Outcome 4 Pancreatic fistula (grade B or C).
Review: Laparoscopic versus open distal pancreatectomy for pancreatic cancer
Comparison: 1 Laparoscopic distal pancreatectomy versus open distal pancreatectomy
Outcome: 4 Pancreatic fistula (grade B or C)
Study or subgroup
Laparoscopic
dist pancr Open dist pancr Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ceppa 2013 0/20 4/20 53.9 % 0.09 [ 0.00, 1.78 ]
Hu 2014 0/11 0/23 Not estimable
Rehman 2014 1/8 2/14 15.6 % 0.86 [ 0.07, 11.26 ]
Shin 2015 8/70 3/80 30.4 % 3.31 [ 0.84, 13.01 ]
Total (95% CI) 109 137 100.0 % 1.19 [ 0.47, 3.02 ]
Total events: 9 (Laparoscopic dist pancr), 9 (Open dist pancr)
Heterogeneity: Chi2 = 5.08, df = 2 (P = 0.08); I2 =61%
Test for overall effect: Z = 0.37 (P = 0.71)
Test for subgroup differences: Not applicable
0.005 0.1 1 10 200
Favours laparoscopic Favours open
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Analysis 1.5. Comparison 1 Laparoscopic distal pancreatectomy versus open distal pancreatectomy,
Outcome 5 Recurrence at maximal follow-up.
Review: Laparoscopic versus open distal pancreatectomy for pancreatic cancer
Comparison: 1 Laparoscopic distal pancreatectomy versus open distal pancreatectomy
Outcome: 5 Recurrence at maximal follow-up
Study or subgroup
Laparoscopic
dist pancr Open dist pancr Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Hu 2014 2/11 11/23 20.6 % 0.24 [ 0.04, 1.38 ]
Shin 2015 35/70 48/80 79.4 % 0.67 [ 0.35, 1.27 ]
Total (95% CI) 81 103 100.0 % 0.58 [ 0.32, 1.05 ]
Total events: 37 (Laparoscopic dist pancr), 59 (Open dist pancr)
Heterogeneity: Chi2 = 1.15, df = 1 (P = 0.28); I2 =13%
Test for overall effect: Z = 1.79 (P = 0.074)
Test for subgroup differences: Not applicable
0.05 0.2 1 5 20
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Analysis 1.6. Comparison 1 Laparoscopic distal pancreatectomy versus open distal pancreatectomy,
Outcome 6 Adverse events (proportion).
Review: Laparoscopic versus open distal pancreatectomy for pancreatic cancer
Comparison: 1 Laparoscopic distal pancreatectomy versus open distal pancreatectomy
Outcome: 6 Adverse events (proportion)
Study or subgroup
Laparoscopic
dist pancr Open dist pancr Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ceppa 2013 7/20 12/20 31.0 % 0.36 [ 0.10, 1.29 ]
Hu 2014 5/11 12/23 16.8 % 0.76 [ 0.18, 3.23 ]
Rehman 2014 3/8 6/14 10.8 % 0.80 [ 0.13, 4.74 ]
Shin 2015 18/70 15/80 41.3 % 1.50 [ 0.69, 3.26 ]
Total (95% CI) 109 137 100.0 % 0.95 [ 0.54, 1.66 ]
Total events: 33 (Laparoscopic dist pancr), 45 (Open dist pancr)
Heterogeneity: Chi2 = 3.67, df = 3 (P = 0.30); I2 =18%
Test for overall effect: Z = 0.19 (P = 0.85)
Test for subgroup differences: Not applicable
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Analysis 1.7. Comparison 1 Laparoscopic distal pancreatectomy versus open distal pancreatectomy,
Outcome 7 Length of hospital stay.
Review: Laparoscopic versus open distal pancreatectomy for pancreatic cancer
Comparison: 1 Laparoscopic distal pancreatectomy versus open distal pancreatectomy
Outcome: 7 Length of hospital stay
Study or subgroup
Laparoscopic
dist pancr Open dist pancr
Mean
Difference Weight
Mean
Difference
N Mean(SD)[days] N Mean(SD)[days] IV,Random,95% CI IV,Random,95% CI
Hu 2014 11 5.2 (2.5) 23 8.6 (3.9) 10.5 % -3.40 [ -5.57, -1.23 ]
Kooby 2010 23 7.4 (3.4) 70 9.4 (4.7) 15.7 % -2.00 [ -3.77, -0.23 ]
Rehman 2014 8 8 (4.3) 14 12 (4.3) 3.5 % -4.00 [ -7.74, -0.26 ]
Sharpe 2015 144 6.8 (4.6) 625 8.9 (7.5) 54.3 % -2.10 [ -3.05, -1.15 ]
Shin 2015 70 9 (5.5) 80 12 (5.5) 15.9 % -3.00 [ -4.76, -1.24 ]
Total (95% CI) 256 812 100.0 % -2.43 [ -3.13, -1.73 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.53, df = 4 (P = 0.64); I2 =0.0%
Test for overall effect: Z = 6.77 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.8. Comparison 1 Laparoscopic distal pancreatectomy versus open distal pancreatectomy,
Outcome 8 Positive resection margins.
Review: Laparoscopic versus open distal pancreatectomy for pancreatic cancer
Comparison: 1 Laparoscopic distal pancreatectomy versus open distal pancreatectomy
Outcome: 8 Positive resection margins
Study or subgroup
Laparoscopic
dist pancr Open dist pancr Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Braga 2015 8/30 11/34 13.2 % 0.76 [ 0.26, 2.24 ]
Dancea 2012 0/4 1/10 1.4 % 0.70 [ 0.02, 20.91 ]
Hu 2014 0/11 0/23 Not estimable
Kooby 2010 6/23 24/70 13.8 % 0.68 [ 0.24, 1.94 ]
Lee 2015 0/19 30/249 2.0 % 0.18 [ 0.01, 3.13 ]
Rehman 2014 1/8 2/14 2.4 % 0.86 [ 0.07, 11.26 ]
Sharpe 2015 17/144 127/625 44.5 % 0.52 [ 0.31, 0.90 ]
Shin 2015 17/70 13/80 22.6 % 1.65 [ 0.74, 3.71 ]
Vijan 2010 0/20 0/21 Not estimable
Zhang 2014 0/4 0/7 Not estimable
Total (95% CI) 333 1133 100.0 % 0.74 [ 0.49, 1.10 ]
Total events: 49 (Laparoscopic dist pancr), 208 (Open dist pancr)
Heterogeneity: Tau2 = 0.02; Chi2 = 6.36, df = 6 (P = 0.38); I2 =6%
Test for overall effect: Z = 1.49 (P = 0.14)
Test for subgroup differences: Not applicable
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Analysis 2.1. Comparison 2 Subgroup analysis (stapler only), Outcome 1 Short-term mortality.
Review: Laparoscopic versus open distal pancreatectomy for pancreatic cancer
Comparison: 2 Subgroup analysis (stapler only)
Outcome: 1 Short-term mortality
Study or subgroup
Laparoscopic
dist pancr Open dist pancr Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Shin 2015 0/70 1/80 100.0 % 0.38 [ 0.02, 9.38 ]
Zhang 2014 0/4 0/7 Not estimable
Total (95% CI) 74 87 100.0 % 0.38 [ 0.02, 9.38 ]
Total events: 0 (Laparoscopic dist pancr), 1 (Open dist pancr)
Heterogeneity: not applicable
Test for overall effect: Z = 0.60 (P = 0.55)
Test for subgroup differences: Not applicable
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Analysis 2.2. Comparison 2 Subgroup analysis (stapler only), Outcome 2 Long-term mortality.
Review: Laparoscopic versus open distal pancreatectomy for pancreatic cancer
Comparison: 2 Subgroup analysis (stapler only)
Outcome: 2 Long-term mortality
Study or subgroup log [Hazard Ratio] Hazard Ratio Weight Hazard Ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
Shin 2015 -0.13174 (0.137829) 100.0 % 0.88 [ 0.67, 1.15 ]
Total (95% CI) 100.0 % 0.88 [ 0.67, 1.15 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.96 (P = 0.34)
Test for subgroup differences: Not applicable
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Analysis 2.3. Comparison 2 Subgroup analysis (stapler only), Outcome 3 Serious adverse events
(proportion).
Review: Laparoscopic versus open distal pancreatectomy for pancreatic cancer
Comparison: 2 Subgroup analysis (stapler only)
Outcome: 3 Serious adverse events (proportion)
Study or subgroup
Laparoscopic
dist pancr Open dist pancr Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Shin 2015 5/70 2/80 100.0 % 3.00 [ 0.56, 15.98 ]
Total (95% CI) 70 80 100.0 % 3.00 [ 0.56, 15.98 ]
Total events: 5 (Laparoscopic dist pancr), 2 (Open dist pancr)
Heterogeneity: not applicable
Test for overall effect: Z = 1.29 (P = 0.20)
Test for subgroup differences: Not applicable
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Analysis 2.4. Comparison 2 Subgroup analysis (stapler only), Outcome 4 Pancreatic fistula (grade B or C).
Review: Laparoscopic versus open distal pancreatectomy for pancreatic cancer
Comparison: 2 Subgroup analysis (stapler only)
Outcome: 4 Pancreatic fistula (grade B or C)
Study or subgroup
Laparoscopic
dist pancr Open dist pancr Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Shin 2015 8/70 3/80 100.0 % 3.31 [ 0.84, 13.01 ]
Total (95% CI) 70 80 100.0 % 3.31 [ 0.84, 13.01 ]
Total events: 8 (Laparoscopic dist pancr), 3 (Open dist pancr)
Heterogeneity: not applicable
Test for overall effect: Z = 1.72 (P = 0.086)
Test for subgroup differences: Not applicable
0.005 0.1 1 10 200
Favours laparoscopic Favours open
58Laparoscopic versus open distal pancreatectomy for pancreatic cancer (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 3.1. Comparison 3 Sensitivity analysis, Outcome 1 Length of hospital stay.
Review: Laparoscopic versus open distal pancreatectomy for pancreatic cancer
Comparison: 3 Sensitivity analysis
Outcome: 1 Length of hospital stay
Study or subgroup
Laparoscopic
dist pancr Open dist pancr
Mean
Difference Weight
Mean
Difference
N Mean(SD)[days] N Mean(SD)[days] IV,Random,95% CI IV,Random,95% CI
Hu 2014 11 5.2 (2.5) 23 8.6 (3.9) 13.0 % -3.40 [ -5.57, -1.23 ]
Kooby 2010 23 7.4 (3.4) 70 9.4 (4.7) 19.5 % -2.00 [ -3.77, -0.23 ]
Sharpe 2015 144 6.8 (4.6) 625 8.9 (7.5) 67.5 % -2.10 [ -3.05, -1.15 ]
Total (95% CI) 178 718 100.0 % -2.25 [ -3.03, -1.47 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.25, df = 2 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 5.63 (P < 0.00001)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours laparoscopic Favours open
A P P E N D I C E S
Appendix 1. CENTRAL search strategy
#1 (pancreas)
#2 (pancrea*)
#3 MeSH descriptor: [Pancreas] explode all trees
#4 #1 or #2 or #3
#5 MeSH descriptor: [Carcinoma] this term only
#6 MeSH descriptor: [Adenocarcinoma] this term only
#7 MeSH descriptor: [Carcinoma, Ductal] this term only
#8 MeSH descriptor: [Neoplasms] explode all trees
#9 (cancer* or carcin* or neoplas* or tumo* or cyst* or growth* or adenocarcin* or malig*)
#10 #5 or #6 or #7 or #8 or #9
#11 #4 and #10
#12 Pancreatectomy
#13 MeSH descriptor: [Pancreatectomy] explode all trees
#14 #12 or #13
#15 (laparoscopy or laparoscopic)
#16 MeSH descriptor: [Laparoscopy] explode all trees
#17 #15 or #16
#18 #11 and #14 and #17
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Appendix 2. MEDLINE search strategy
1. (pancreas or pancrea*).mp.
2. exp Pancreas/
3. 1 or 2
4. Carcinoma/
5. Adenocarcinoma/
6. Carcinoma, Ductal/
7. exp Neoplasms/
8. (cancer* or carcin* or neoplas* or tumo* or cyst* or growth* or adenocarcin* or malig*).mp.
9. 4 or 5 or 6 or 7 or 8
10. 3 and 9
11. Pancreatectomy.mp.
12. exp Pancreatectomy/
13. 11 or 12
14. (laparoscopy or laparoscopic).mp.
15. exp Laparoscopy/
16. 14 or 15
17. 13 and 16
18. 10 and 17
Appendix 3. EMBASE search strategy
1. (pancreas or pancrea*).mp.
2. exp pancreas/
3. 1 or 2
4. carcinoma/ or adenocarcinoma/ or carcinoma, ductal/
5. exp neoplasms/
6. (cancer* or carcin* or neoplas* or tumo* or cyst* or growth* or adenocarcin* or malig*).mp.
7. 4 or 5 or 6
8. 3 and 7
9. Pancreatectomy.mp.
10. exp Pancreatectomy/
11. 9 or 10
12. (laparoscopy or laparoscopic).mp.
13. exp laparoscopy/
14. 12 or 13
15. 11 and 14
16. 8 and 15
Appendix 4. Science Citation Index search strategy
#1 TS=(pancreas or pancrea*)
#2 TS=(cancer* or carcin* or neoplas* or tumo* or cyst* or growth* or adenocarcin* or malig*)
#3 TS=(Pancreatectomy)
#4 TS=(laparoscopy or laparoscopic)
#5 #4 AND #3 AND #2 AND #1
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Appendix 5. ClinicalTrials.gov search strategy
“Interventional” [STUDY-TYPES] AND pancreatic cancer [DISEASE] AND laparoscopic distal pancreatectomy [TREATMENT]
AND ( “Phase 2” OR “Phase 3” OR “Phase 4” ) [PHASE]
Appendix 6. WHO ICTRP search strategy
Distal pancreatectomy AND laparoscop*
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S O U R C E S O F S U P P O R T
Internal sources
• University College London, UK.
External sources
• National Institute for Health Research, UK.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
1. No randomised controlled trials were identified; therefore, we included non-randomised studies to provide the current best
available evidence. As a result, we made the following modifications to the protocol.
i) We did not use the filter for randomised controlled trials during electronic searches of the databases.
ii) We used ’A Cochrane Risk Of Bias Assessment Tool: for Non-Randomized Studies of Interventions’ (ACROBAT-NRSI)
for assessment of risk of bias, rather than the standard Cochrane ’Risk of bias’ tool for randomised controlled trials.
2. We planned to calculate the risk ratio for binary outcomes. However, because case-control studies were included, we calculated
the odds ratio because it is not possible to calculate the baseline risk in case-control studies.
3. We planned to calculate the hazard ratio for long-term recurrence. However, data were not available in the format required for
calculating the hazard ratio. So we calculated the odds ratio.
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